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Although exocytosis is the major mechanism by which cells 
secrete products into their environment, little is known 
about the mechanism of this fundamental process. Previous 
studies on the regulation of luteinizing hormone (LH) 
exocytosis have used intact cells exclusively. It is not 
possible, however, to determine the precise requirements for 
exocytosis in intact cells since the cytosol is not directly 
accessible. Permeabilization of the plasma membrane allows 
experimental manipulation of the intracellular milieu while 
preserving the exocytic apparatus. The diameter of the a-
toxin pores (2-3 nm) allowed the exchange of small molecules 
such as ATP while larger cytosolic proteins such as lactate 
dehydrogenase were retained. Because of the slow exchange of 
small molecules through a-toxin pores a protocol was 
developed which combines prolonged pre-equilibration of the 
permeabilized cells at 0°C before stimulation with strong 
ca2+ buffering. Under these conditions an increase in the 
[ca2+]free stimulated a 15-20 fold increase in LH exocytosis 
(EC50 pCa 5.5). After 12-15 minutes the rate of exocytosis 
declined and the cells became refractory to ca2+. At resting 
[ca2+]free (pea 7), cAMP stimulated a rapid, 2 - 3 fold, 
increase in LH exocytosis. cAMP caused a modest enhancement 
of ca2+-stimulated LH exocytosis by causing a left shift in 
the EC50 for ca2+ from pCa 5.6 to pCa 5.9. Activation of 
protein kinase C (PKC) with phorbol 12-myristate 13-acetate 
(PMA) synergistically enhanced cAMP-stimulated LH 
exocytosis, an effect which was further_ augmented by 
increasing the [ca2+]free· Gonadotrophin-releasing hormone 
(GnRH) was found to stimulate cAMP production in intact 
pituitary cells. Since previous studies have shown that GnRH 
activates PKC and stimulates a rise in cytosolic [ca2+]free, 
these results suggest that a synergistic interaction of the 
cAMP, PKC and ca2+ second messenger systems is of importance 
in the mechanism of GnRH-stimulated LH exocytosis. 
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When permeabilized cells were equilibrated for prolonged 
periods in the absence of MgATP, ca2+_stimulated LH 
exocytosis declined. The time course of the decline closely 
followed the leakage of intracellular 14c-ATP. Addition of 
MgATP rapidly restored full ca2+ -stimulated LH exocytosis. 
ca2+_, cAMP-, and PMA-stimulated LH exocytosis were all 
dependent on millimolar MgATP concentrations (EC50 1 .5-3 
mM). 
It has been postulated that PKC is a mediator of ca2+_ 
stimulated exocytosis. Several findings in the present study 
argue against this hypothesis. Firstly, PMA and ca2+ had 
additive effects on LH exocytosis at all [Ca2+]free· 
Secondly, PMA was able to stimulate further LH release from 
cells made refractory to high [ca2+]free· Thirdly, the PKC 
inhibitor staurosporine did not inhibit ca2+-stimulated LH 
exocytosis under conditions in which it inhibited PMA-
stimulated exocytosis. Fourthly, in cells desensitized to 
PMA by prolonged exposure to a high PMA concentrations, 
ca2+_stimulated LH exocytosis was not inhibited. And 
finally, Ba2+ was able to stimulate LH exocytosis to a 
maximal extent similar to ca2+ despite the fact that Ba2+ is 
an extremely poor activator of PKC. Since Ba2+ is also a 
poor activator of calmodulin, this latter result implies 
that calmodulin does not mediate the effect of ca2+. In 
agreement with this, the calmodulin inhibitor calmidazolium 
did not inhibit ca2+~stimulated LH exocytosis. 
Since GTP-binding proteins have been implicated in regulated 
exocytosis in other cell systems, the effects of guanine 
nucleotides on LH exocytosis were examined. At resting 
cytosolic [ca2+]free (pea 7), the GTP analogues GTPyS and 
GMPPNP stimulated LH exocytosis with similar potencies (EC50 
20-50 µM). Additional experiments indicated that the effects 
of these GTP analogues could not be explained by activation 
of either PKC alone or cAMP-dependent protein kinase alone. 
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In the presence of both PMA and cAMP, GMPPNP did not 
stimulate a further increase in the rate of LH exocytosis, 
suggesting that the stimulatory actions of guanine 
nucleotides may be mediated by the combined activation of 
PKC and generation of cAMP, as a result of activation of 
signal-transducing G proteins. In contrast, pretreatment of 
cells with GTPyS at low [ca2+]free markedly inhibited 
subsequent responses to ca2+, cAMP, PMA, and cAMP plus PMA. 
This inhibitory effect required lower GTPyS concentrations 
than the stimulatory effect (IC50 1-10 µM), and was not 
observed with GMPPNP. These findings indicate the 
involvement of a distinct guanine nucleotide-binding protein 
in exocytosis at a site distal to second messenger 
generation. 
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1 GENERAL INTRODUCTION 
Exocytosis is the major mechanism by which cells export 
material into their environment. Until recently little was 
known about the mechanism of this fundamental process. 
However, the development of cell permeabilization techniques 
over the past decade has coincided with a recent dramatic 
increase in exocytosis research. The first part of this 
introduction (Section 1 .1) reviews what is known about 
exocytosis. The second part of the introduction (Section 
1.2) provides an overview of the models used for studying 
exocytosis as well as the various cell permeabilization 
techniques available. a-Toxin permeabilization is described 
in some detail. The regulation of exocytosis in gonadotropes 
is discussed in the final part of t h e introduction (Section 
1 .3) but only briefly since it is dealt with in more detail 
in later sections. 
1.1 EXOCYTOSIS 
1.1.1 Regulated and constitutive exocytosis. 
Proteins destined for export from the cell are synthesized 
by ribosomes associated with the endoplasmic reticulum (ER), 
and pass into the ER cisternal space during or soon after 
synthesis (Alberts et al., 1989; Verner and Schatz, 1988). 
After preliminary processing in the ER these proteins are 
transported within membrane bound vesicles through the Golgi 
apparatus where processing is continued (Palade, 1975; 
Burgess and Kelly, 1987). On leaving the Golgi apparatus, 
secretory proteins enter the trans-Golgi network (TGN; 
Griffiths and Simons, 1986) where they are sorted into one 
of two pathways, both of which are present in anterior 
pituitary cells (Kelly, 1985; Burgess and Kelly, 1987). Some 
proteins (eg. albumin, immunoglobulin G) are transported 
directly to the plasma membrane in membraneous vesicles 
which fuse with the plasma membrane, releasing their 
contents to the cell exterior in a continuous, unregulated 
manner. This process is referred to as constitutive 
exocytosis. In contrast, proteins such as hormones are 
packaged in large amounts into secretory vesicles which are 
stored in the cell, only fusing with the plasma membrane 
when an appropriate signal is received. The latter process 
is called regulated exocytosis and is the mechanism by which 
specialized secretory cells such as neurons, exocrine, and 
endocrine cells release their secretory products. Biogenic 
amines such as catecholamines and acetylcholine are also 
stored in specialized secretory vesicles before release by 
regulated exocytosis although clearly their synthetic 
pathway differs to that of proteins (Pollard et al., 1985). 
1.1.2. Stimulus-secretion coupling. 
Many cell types secrete hormones or other products in 
response to a stimulus. For example, anterior pituitary 
gonadotropes secrete the gonadotropins luteinizing hormone 
(LH) and follicle-stimulating hormone (FSH) when stimulated 
by the hypothalamic decapeptide gonadotrophin-releasing 
hormone (GnRH) (for reviews see Hazum and Conn, 1988; Huckle 
and Conn, 1988). The process by which GnRH stimulation leads 
to gonadotropin secretion is referred to as stimulus-
secretion coupling and may be divided into two stages. The 
first stage begins with the binding of GnRH to its cell 
surface receptor and results in the generation of 
intracellular second messengers such as ca2+, cAMP, and 
diacylglycerol (Borgeat et al., 1972, Andrews and Conn, 
1986; Limor et al., 1987). The second stage is initiated by 
increased levels of intracellular second messengers and 
culminates in the release, by regulated exocytosis, of 
stored LH and FSH. 
Although much is known about how cell stimulation results in 
generation of intracellular second messengers (Berridge, 
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1987; Levitzki, 1988), the precise mechanisms by which 
intracellular second messengers stimulate regulated 
exocytosis are not well understood in any cell type. ca2+ 
was long held to be the most important intracellular second 
messenger responsible for regulating secretory exocytosis in 
a wide variety of cell types (see Rink and Knight, 1988; 
Knight et al. ,1989). Recently, however, it has become clear 
that other second messengers, including cAMP (Takuma and 
Ichida, 1988; and this study) and diacylglycerol [or its 
analogue phorbol 12-myristate 13-acetate (PMA)] (Di Virgilio 
et al., 1984; Pozzan et al., 1984; and this study), can 
stimulate secretory exocytosis in the absence of any change 
in cytosolic [ca2+]free· Furthermore, guanine nucleotide 
analogues can stimulate exocytosis independently of changes 
in [ca2+]free (Haslam and Davidson, 1984; Barrowman et al., 
1986). Although the mechanism of the guanine nucleotide-
stimulation is not known (see Section 5), this finding 
confirms that an increase in [ca2+]free is not essential for 
secretory exocytosis to occur. 
1 . 1.3 Steps in regulated exocytosis. 
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1.1.3.1 Formation of secretory vesicles 
Proteins destined for regulated exocytosis need to be sorted 
from constitutively-secreted proteins and packaged into 
specialized secretory vesicles in concentrated form for 
storage (Burgess and Kelly, 1987). These secretory vesicles 
are also termed secretory granules since their high content 
of electron-dense material results in a granular appearance 
in electron micrographs (Burgess and Kelly, 1987). The 
sorting process takes place in the trans-Golgi network 
(Griffiths and Simons, 1986), and appears to involve the 
active separation of "regulated" proteins from the bulk-flow 
secretory pathway down which "constitutive" proteins are 
passively transported (Moore et al., 1983). Sorting may be 
mediated by a group of Mr 25 000 proteins purified from 
pancreas Golgi which are able to distinguish "regulated" 
from "constitutive" proteins (Chung et al., 1989). 
Morphological studies suggest that clathrin may be involved 
in the formation of secretory granules, perhaps by removing 
excess membrane from the condensing secretory vesicle and/or 
by recycling resident TGN proteins from the newly formed 
secretory vesicle back to the TGN (Brodsky, 1988). 
1.1.3.2 Transport of secretory vesicles to their plasma 
membrane fusion sites. 
Newly formed secretory vesicles need to move from the Golgi 
to their sites of fusion at the plasma membrane. There are 
two distinct components to this movement. Immediately after 
formation, secretory vesicles need to be transported from 
the Golgi to a storage site near the plasma membrane. This 
-is often, as in neurons, a considerable distance. There is 
evidence that microtubules are involved in this process and 
that it is not regulated by second messengers (Burgess and 
Kelly, 1987; Rivas and Moore, 1989). In contrast, second 
messenger systems do regulate the movement of secretory 
vesicles from these sub-plasmalemmal storage sites into the 
the immediate vicinity of the plasma membrane fusion sites. 
The microfilament (actin-containing) cytoskeleton may be 
involved in this movement but its role seems to be mainly 
passive in that it acts as a barrier between secretory 
vesicles and the plasma membrane (see Section 1.1 .4.2). In 
some cell types, including neurons (Heuser et al., 1979) and 
oocytes (Sasaki and Epel, 1983) as well_ as the in protozoa 
Tetrahymena (Satir et al., 1973) and Paramecium (Plattner et 
al., 1982), a large proportion of secretory vesicles appear 
to be prepositioned at their plasma membrane fusion sites 
for rapid release. 
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1.1.3.3. Fusion of the secretory vesicle with the plasma 
membrane. 
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As a result of fusion of the secretory vesicle membrane with 
the plasma membrane, the vesicle lumen becomes continuous 
with the extracellular space. Theoretical considerations 
(Blumenthal, 1987) suggest that the major barriers to 
membrane fusion are the water associated with membrane 
surfaces and the electrostatic repulsion of like-charged 
phospholipid head groups (both of which prevent close 
approach of the membranes). Any model proposed for membrane 
fusion will need to suggest mechanisms for overcoming these 
barriers. Recent morphological (Chandler, 1984) and 
electrophysiological (Fernandez et al., 1984; Breckenridge 
and Almers, 1987; Zimmerberg, 1987; Spruce et al., 1989) 
studies indicate that the first step in membrane fusion is 
the reversible formation of a small "fusion pore". 
Measurements of ion conductance indicate that this pore has 
a diameter similar to that of gap junctions, the only known 
biological channel structure which traverses two membranes 
(Loewenstein, 1981). Presumably it is this pore which widens 
to complete the fusion process. Interestingly, structural 
studies of synaptophysin, a major integral membrane protein 
of synaptic vesicles, suggest that it forms hexameric 
transmembrane channels with the same conductance as a fusion 
pore (Thomas et al., 1988). Since this conductance is 
voltage-sensitive (Thomas et al., 1988), being apparent only 
at depolarizing voltages, synaptophysin may confer the 
voltage-sensitivity to ca2+-stimulated exocytosis which has 
been demonstrated in neurons (Hochner et al., 1989). 
1.1.3.4 Expulsion of secretory vesicle contents. 
The expulsion of secretory vesicle contents may occur by 
simple diffusion or by active expulsion. Two mechanisms have 
been proposed for active expulsion. In one, the contraction 
of a microfilament network surrounding fused secretory 
vesicles expels the vesicle contents (Segawa and Yamashina, 
1989; for further discussion see Section 1.1 .4.2). In the 
other, the granule content swelling which is associated with 
exocytosis assists in the dispersal of vesicle contents 
(Bilinski et al., 1981; Green, 1982). The role of osmotic 
forces in exocytosis is discussed in Section 1 .1.5. 
1.1.3.5 Retrieval of secretory vesicle membrane. 
The retrieval of secretory vesicle membrane which has been 
incorporated into the plasma membrane is essential since the 
plasma membrane surface area can increase as much as four 
fold following stimulation of exocytosis (Fernandez et al., 
1984). In the adrenal chromaffin cell, membrane retrieval 
increases two- to three-fold immediately following secretory 
e xocytosis (von Grafenstein et al., 1986). Significantly, it 
is not ca2+-dependent but is temperature-sensitive and 
requires ATP (von Grafenstein et al., 1986; Rink and Knight, 
1988). It appears that secretory vesicle membrane does not 
mix with the plasma membrane (Phillips et al., 1983; Patzak 
and Winkler, 1986; Torri-Tarelli et al., 1990) and is 
efficiently retrieved (Thilo, 1985; Torri-Tarelli et al., 
1990), thus minimizing the turnover of plasma membrane 
which would be wasteful in an active secretory cell. After 
retrieval, some secretory vesicle membrane is recycled into 
newly formed secretory vesicles, probably at the TGN 
(Burgess and Kelly, 1987). 
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1.1.4 Proteins implicated in regulated exocytosis. 
1.1.4.1 Introduction 
Several lines of evidence indicate that one or more 
protein(s) must be involved in the mechanism of regulated 
exocytis. Firstly, not only does exocytosis require the 
overcoming of considerable energy barriers, but it is also 
generally dependent on ATP (see Section 3). Secondly, in the 
absence of proteins, phospholipid vesicles do not fuse in 
the presence of physiological concentrations of ca2+ 
(Blumenthal, 1987). Thirdly, second messenger-stimulated 
exocytosis is abolished by N-ethylmaleimide which modifies 
protein sulphydryl groups (Knight and Baker, 1982). 
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Although no protein has been conclusively demonstrated to be 
essential for regulated exocytosis, many proteins have been 
tentatively implicated. In most cases it is not known at 
which stage in regulated exocytosis these proteins are 
involved. Nor is it known whether these proteins are 
essential for exocytosis or merely regulatory. For these 
reasons they are discussed separately from the previous 
section and in no particular order. 
1.1.4.2 Microfilament proteins 
Many secretory cells possess a dense, subplasmalemmal 
cytoskeletal network composed of filamentous actin (F-actin) 
and various actin binding proteins including fodrin and 
calpactin (Burgoyne and Cheek, 1987; Aunis and Bader, 1988; 
Segawa and Yamashina, 1989; Ikebuchi and Waisman, 1990; 
Nakata et al., 1990). Secretory vesicles are embedded within 
this cytoskeletal network and may be bound to it through 
actin-binding proteins such as synapsin I/II, a-actinin, 
caldesmon, and calpactin, all of which also bind secretory 
vesicle membranes (Burgoyne et al., 1986; Walker and 
Agoston, 1987; Drust and Creutz, 1988). 
In support of a functional role for microfilament proteins 
in exocytosis, F-actin modifying agents such as the 
cytochalasins, phalloidin and botulinum C2 toxin have been 
shown to modify regulated exocytosis (Lelkes et al., 1986; 
Lew et al., 1986; Sontag et al., 1988; Niisse and Lindau, 
1988; Matter et al., 1989). Furthermore, antibodies to the 
a-subunit of fodrin inhibited ca2+-stimulated exocytosis 
when introduced into permeabilized adrenal chromaffin cells 
(Perrin et al., 1987). Fodrin is thought to crosslink F-
actin to the plasma membrane and there is evidence that 
antibodies to fodrin inhibit fodrin degradation by ca2+_ 
activated proteases (Siman et al., 1985). 
Most of the evidence suggests that the sub-plasmalernrnal 
microfilament network has a passive role, preventing 
movement of secretory vesicles to the plasma membrane 
(Stossel, 1981). Nicotine stimulation of intact - and ca2+ 
stimulation of permeabilized - adrenal chromaffin cells 
leads to disassembly of the sub-plasmalemmal microfilament 
network and exocytosis (Cheek and Burgoyne, 1986; Sontag et 
al., 1988). Furthermore, F-actin destabilizing agents such 
as cytochalasins and botulinum C2 ADP-ribosyltransferase 
generally enhance ca2+-stimulated exocytosis (Lelkes et al., 
1986; Lew et al., 1986; Sontag et al., 1988; Matter et al., 
1989). There are several ca2+-sensitive cytoskeletal 
proteins such as gelsolin (Matsudaira and Janmey, 1988) 
activation of which could promote F-actin disassembly. 
In neurons synapsin I (which is not present in non-neuronal 
cells) appears to mediate the binding of synaptic vesicles 
to the subplasmalernrnal microfilament network (see Section 
1.1 .4.4 for references). ca2+ stimulated phosphorylation of 
synapsin I leads to its dissociation from synaptic vesicles, 
providing an attractive mechanism for the effects of ca2+. 
Consistent with a barrier role for microfilaments is the 
finding that in sea urchin eggs, where secretory vesicles 
are prepositioned at their fusion sites, and are therefore 
presumably are not restrained by microfilaments, agents 
which disrupt microfilaments have no effect on ca2+_ 
stimulated exocytosis (Whitaker and Baker, 1983). 
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There is no direct evidence for two other roles proposed for 
microfilaments which are that actin, together with myosin, 
pull secretory vesicles toward the plasma membrane or that 
the subplasmalemmal network provides the force to expel the 
secretory vesicle contents once fusion with the plasma 
membrane has occured (Segawa and Yamashina, 1989). However, 
a recent study demonstrating that calpactin, a member of the 
annexin protein family which is required for ca2+-stimulated 
exocytosis (see Section 1 .1.4.3), mediates ca2+-stimulated 
formation of F-actin bundles provides indirect evidence for 
an active role for the microfilament network (Ikebuchi and 
Waisman, 1990). 
Although microtubules are involved in the transport of 
secretory vesicles from the TGN to their storage sites near 
the plasma membrane (see Section 1.1.3.2), this process is 
not regulated by second messengers. Indeed, there is no 
evidence that microtubules play a role in second messenger-
stimulated exocytosis of stored secretory products (Burgess 
and Kelly, 1987). 
1.1.4.3 Annexins 
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One strategy used to identify proteins involved in 
exocytosis was the purification and characterization of 
soluble proteins which bind chromaffin granule membranes in 
a ca2+-dependent manner (Geisow and Burgoyne, 1982; Creutz 
et al., 1983). It should be emphasized that these proteins 
also bind artificial membranes, indicating that this binding 
is not specific (Creutz et al., 1983). Creutz . et al. (1983, 
1987) have identified 23 such proteins and refer to them as 
"chromobindins". Some of these proteins were subsequently 
identified as calmodulin, protein kinase C, caldesmon, 
synexin and calelectrin (Creutz et al. 1987 and references 
therein). Others have been shown to have sequence similarity 
to the proteins synexin and calelectrin and are clearly part 
of a homologous family of proteins which are collectively 
referred to as "annexins" (Geisow et al., 1987; Burgoyne and 
Geisow, 1989; Burns et al., 1989). Annexins share a common 
sequence motif of about 70 amino acids which is repeated at 
least four times within the protein (Burgoyne and Geisow, 
1989) . 
Synexin is an extremely hydrophobic Mr 47 000 protein which, 
in the presence of ca2+ and cis-unsaturated fatty acids such 
as arachidonic acid, mediates the fusion of chromaffin 
granules in vitro (Pollard et al., 1988). A "hydrophobic 
bridge" model has been proposed in which it is postulated 
that ca2+ stimulates the formation of a synexin polymer, 
which traverses both the plasma membrane and the secretory 
vesicle membrane, thus forming a "hydrophobic bridge" along 
which membrane phospholipids can move and eventually fuse 
(Pollard et al., 1988). However, this model is somewhat 
speculative and direct evidence is required. 
In contrast, there is direct evidence that another annexin, 
calpactin, may mediate ca2+-stimulated exocytosis. Like 
synexin, calpactin has been shown to mediate ca2+-dependent 
aggregation of chromaffin granules (Drust and Creutz, 1988). 
However, whereas synexin required >80 µM [ca2+]free for 
detectable aggregation, calpactin induced aggregation at 0.7 
µM [ca2+]free, well within the physiological cytosolic 
[ca2+]free range (Drust and Creutz, 1988). Calpactin also 
reconstituted ca2+-dependent exocytosis in permeabilized 
adrenal chromaffin cells which had lost their ability to 
secrete because of leakage of cytosolic proteins (Ali et 
al., 1989). And finally, a synthetic 20 amino acid annexin 
consensus peptide inhibited ca2+-stimulated exocytosis in 
these cells and this inhibition was reversed by calpactin 
(Ali et al., 1989). Calpactin is a tetramer composed of two 
large (Mr 36 000) and two small (Mr 10 000) subunits and has 
a wide tissue distribution (Burgoyne and Geisow, 1989). In 
adrenal chromaffin cells, calpactin is localized on the 
inner face of the plasma membrane (Nakata et al., 1990) and 
is phosphorylated after nicotine stimulation (Burgoyne and 
Geisow, 1989). In vitro and in vivo studies indicate that 
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calpactin is a substrate for retroviral tyrosine kinases, 
protein kinases A and C, as well as ca2+ /calmodulin 
dependent protein kinase (Burgoyne and Geisow, 1989). The 
name calpactin originally derived from its ability to bind 
actin in the presence of high ca2+ concentrations (Glerk and 
Weber, 1984). More recently calpactin has been shown to bind 
F-actin at physiological [ca2+]free (Km< 1 µM) and mediate 
ca2+-stimulated bundling of F-actin fibres (Ikebuchi and 
Waisman, 1990; see Section 1.1.4.2). 
1.1.4.4 Synapsin I 
Synapsin I is a heterodimer of closely related polypeptides 
of Mr 86 000 and 80 000 and is found exclusively in neuronal 
tissue (for review see Hemmings et al., 1989). It is present 
in virtually all synaptic termini where it is localized to 
the cytosolic surface of small synaptic vesicles, 
constituting 6 % of total vesicle protein. Morphological 
studies (Hirokawa et al., 1989) indicate that synapsin I 
binds secretory vesicles to the presynaptic microfilamentous 
cytoskeletal network. Phosphorylation of synapsin I by 
ca2+/calmodulin-dependent protein kinase II (Ca/CAM kinase 
II) in vitro leads to its dissociation from synaptic 
vesicles (Schiebler et al., 1986). Depolarization of 
isolated rat nerve terminals, which is followed by an 
increase in intraterminal [ca2+]free, leads to 
phosphorylation of synapsin I and its dissociation from the 
particulate to the soluble fraction (Sihra et al., 1989). 
Intracellular introduction of Ca/CAM kinase II enhances 
ca2+_stimulated neurotransmitter release whereas both 
dephospho-synapsin I and a peptide inhibitor of Ca/CAM 
kinase II are inhibitory (Llinas et al., 1985; Nichols et 
al., 1990). Based on these findings it has been postulated 
that in neurons ca2+ stimulates exocytosis at least in part 
by activating ca2+/cAM kinase II. Activated Ca/CAM kinase 
II phosphorylates synapsin I, decreasing its affinity for 
synaptic vesicles. As a result, synaptic vesicles which are 
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bound to the cytoskeleton through synapsin I are free to 
fuse with the plasma membrane (Hemmings et al., 1989). 
1.1.4.5 Parafusin 
In the ciliated protozoa, Paramecium tetraulia, stimulation 
of exocytosis requires the ca2+-dependent dephosphorylation 
of a 63 000 Mr cytosolic phosphoprotein termed parafusin 
(Satir et al., 1988) which may be mediated by a 
ca2+/calmodulin dependent protein phosphatase similar to 
calcineurin (Momayesi et al., 1987). In several P. tetraulia 
temperature-sensitive secretory mutants dephosphorylation of 
parafusin does not occur at the non-permissive temperature 
(Gilligan and Satir, 1982; Zeiseniss and Plattner, 1985). 
Using polyclonal antibodies against parafusin Satir et al. 
(1989) have identified this protein in yeast, insects, and 
mammals, suggesting that it may have a universal role in 
exocytosis. 
1.1.4.6 51K Chromaffin Granule Binding Protein (CGBP) 
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Meyer and Burger (1979) have purified a Mr 51 000 plasma 
membrane protein from adrenal chromaffin cells which binds 
selectively, and in a ca2+-independent manner, to chromaffin 
granules and not to other membranous organelles. CGBP 
differs from chromobindins (see Section 1.1.4.3) in that: 
(i) it is a plasma membrane protein rather than a soluble 
protein; (ii) its binding is selective for chromaffin 
granule membrane; and (iii) it binds chromaffin granules in 
a ca2+-independent manner. These properties, taken together 
with the recent finding that intracellular application of 
antibodies to CGBP abolished depolarization-induced 
exocytosis from rat pheochromocytoma (PC12) and adrenal 
chromaffin cells (Schweitzer et al., 1989), implicate CGBP 
in regulated exocytosis. 
1.1.4.7 Miscellaneous Proteins 
Studies using metalloendoprotease active site analogue 
inhibitors suggest that this enzyme(s) may be involved in 
ca2+-stimulated exocytosis in mast cells (Mundy and 
Strittmatter, 1985) and in both secretory and endocytic 
pathways in hepatoma cells (Strous et al., 1988). However, 
recent studies cast doubt on this intepretation since these 
inhibitors have non-specific effects on phospholipid 
bilayers (Aiello, et al., 1986; Epand et al., 1987; Thomas 
and Meizel, 1989). 
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Intracellular application of botulinum A, D, and E 
neurotoxins and tetanus neurotoxins inhibit ca2+-stimulated 
exocytosis in adrenal chromaffin cells (Knight et al., 1985; 
Penner et al., 1986; Bittner et al., 1989). Since these 
neurotoxins may act on proteins, attempts have been made to 
identify their substrates. Unfortunately, the finding that 
botulinum D toxin apparently ADP-ribosylates Mr 20-22 000 
proteins (Adam-Vizi and Knight, 1988), one of which is a 
small ras-related GTP-binding protein (Morii et al., 1988; 
Narumiya et al., 1988), has been shown to be due to 
contamination with a botulinum ADP-ribosyl transferase which 
does not inhibit exocytosis (Rosener et al., 1987; Narumiya 
et al., 1988). Therefore the target(s) for these neurotoxins 
remain(s) unidentified. 
An attractive new approach to identifying proteins involved 
in regulated exocytosis is based on the finding that 
permeabilized cells which leak proteins frequently lose 
their ability to secrete in response to stimuli such as ca2+ 
(Sarafian et al., 1987; Ali et al., 1989; Keffer and 
Gomperts, 1989; Martin and Walent, 1989a). Martin and Walent 
(1989a) found that responsiveness to ca2+ could be 
reconstituted in permeabilized GH3 pituitary cells by adding 
back soluble proteins prepared from various tissues. Using 
these permeabilized cells as a bioassay, they have purified 
a single Mr 135 000 protein, termed calekkrin, from rat 
brain, which is apparently sufficient to restore ca2+_ 
stimulated exocytosis (Martin and Walent, 1989a; Martin and 
Walent, 1989b). 
Dekker et al. (1989) have recently shown that introduction 
of antibodies to B-50 (a neuron-specific, pre-synaptic, 
protein kinase C substrate) into permeabilized synaptosomes 
inhibits ca2+-stimulated exocytosis suggesting a role for 
this protein in regulated exocytosis. 
Other proteins which have been implicated in exocytosis are 
discussed below. These include protein kinase C (Section 4), 
calmodulin (Section 4) , and GTP-binding proteins (Section 
5 ) • 
1.1.5 The Role of Osmotic Forces in Regulated Exocytosis 
Despite extensive research a role for osmotic forces in 
regulated exocytosis has not been estabilished but nor has 
it been conclusively ruled out (for reviews see Baker and 
Knight, 1984; Holz, 1986). Two distinct roles for osmotic 
forces have been proposed. 
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First, osmotic forces have been postulated to provide the 
driving force for membrane fusion (Pollard et al., 1978; 
Zimmerberg et al., 1980). It is proposed that stimulation 
leads to swelling of secretory vesicles which somehow 
provides the force necessary to overcome the barriers to 
membrane fusion. In favour of this hypothesis are the 
findings that (1) osmotic gradients enhance fusion of lipid 
vesicles with planar lipid membranes (Zimmerburg et al., 
1980); (2) hyperosmolar solutions inhibit exocytosis in 
intact cells (for review see Holz, 1986); and (3) ca2+ 
stimulates swelling of secretory vesicles in vitro 
(Zimmerberg and Whitaker, 1985). Against this hypothesis are 
the findings that (1) visible swelling in vivo occurs only 
after membrane fusion (Breckenridge and Almers, 1987; 
Zimmerberg et al., 1987) and that (2), in permeabilized as 
opposed to intact cells, hyperosmolar solutions do not 
inhibit exocytosis (Holz, 1986). 
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Second, osmotic forces have also been proposed to assist 
dispersal of granule contents following membrane fusion by 
mediating the swelling of granule contents (Bilinski et al., 
1981; Green, 1982). This hypothesis is compatible with the 
finding that granule swelling appears to follow vesicle 
fusion. 
Mechanisms proposed for granule swelling can be divided into 
those that postulate an influx of osmotically active 
particles driven, for example, by a granule membrane H+-
ATPase (for review and critique see Baker and Knight, 1984) 
and those that postulate an increase in the osmotic activity 
of the granule contents as a result, for example, of 
dissociation of protein oligomers into monomers (Lorenson 
and Jacobs, 1984). Both would result in increased osmotic 
activity within the granule which draws water into the 
granule, causing swelling. 
1.2 PERMEABILIZATION 
1.2.1 Models used to Study Regulated Exocytosis 
Early work on regulated exocytosis relied on studies in 
intact cells. Two problems with intact cells are (1) that 
the intracellular environment is inaccesible to precise 
experimental manipulation and (2) that they are too complex, 
making it impossible to elucidate the molecular mechanism of 
exocytosis and identify the proteins involved. 
In an attempt to overcome these problems, cell-free models 
of exocytosis have been developed. The simplest models use 
artificial lipid membranes (Blumenthal, 1987; Rand and 
Parsegian, 1986). Studies have examined fusion of lipid 
vesicles with cells, with other lipid vesicles, or with 
planar lipid membranes (Blumenthal, 1987). A clear advantage 
of these models is that the components of the system a re 
defined and they have provided useful information on the 
forces which may be involved in membrane fusion (Blumenthal, 
1987). However, it is doubtful whether fusion observed in 
these models resembles in vivo exocytosis (Blumenthal, 
1987) . 
The rationale for models in which the fusion of isolated 
secretory vesicles with each other is examined is that this 
is what occurs in compound exocytosis in which secretory 
vesicles expel their contents by fusing with secretory 
vesicles that have ' already fused to the plasma membrane. 
Although this system is attractive it is clearly doubtful 
that vesicle-vesicle fusion is identical to exocytosis. 
Furthermore, chromaffin granules are the secretory vesicle 
most frequently used in these studies (Ekerdt et al., 1981) 
even though compound exocytosis is rare in adrenal 
chromaffin cells (Burgoyne, 1984). 
More promising are models in which the fusion of isolated 
secretory vesicles with plasma membranes are examined. In 
what is arguably the best of these models, isolated sea 
urchin egg secretory vesicles can be induced, by micromolar 
[ca2+]free, to fuse with an egg "plasma membrane lawn" 
attached to a microscope slide (Crabb and Jackson, 1985). 
Recently, Nadin et al. (1989) claim to have demonstrated 
fusion between purified pancreatic secretory vesicles and 
plasma membrane fragments in suspension. In the sea urchin 
egg model exocytosis occurs without adding any other 
component except ca2+ (in Crabb and Jackson, 1985). The 
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pancreas secretory vesicle model remains to be validated 
since it is not clear that fusion rather than simple vesicle 
lysis is occuring. 
Undoubtedly the most widely used, and arguably the most 
successful, model for studying exocytosis is the 
permeabilized cell (for Reviews see Gomperts and Fernandez, 
1985; Knight and Scrutton, 1986; Ahnert-Hilger et al., 
1989). In permeabilized cells the integrity of the plasma 
membrane is disrupted in a manner which allows manipulation 
of the intracellular environment but does not disrupt the 
exocytic process. The most widely used methods for cell 
permeabilization are described below (see Section 1.2.2). 
The existence of so many different methods can be ascribed 
to (1) the particular advantages that individual methods 
have and (2) the adoption of permeabilization techniques 
originally developed for use in fields other than exocytosis 
research. 
1.2.2. Permeabilization Techniques 
30 
The techniques used for permeabilization can be divided 
according to (a) whether the permeabilization is reversible 
and (b) whether they render the plasma membrane permeable to 
small or large molecules (Table 1). Some of these techniques 
have been found to be effective in only a limited number of 
cell types, usually for obscure reasons. For example, ATP4 
permeabilizes rat masts cells (Gomperts, 1983), several 
mouse cell lines (Rozengurt, et al., 1977; Greenberg et al., 
1988), as well as rat anterior pituitary cells (Andrews et 
al., 1986) but is without effect in many other cell types 
examined including sheep anterior pituitary cells (van der 
Merwe et al., 1989b). 
TABLE 1 CELL PERMEABILIZATION TECHNIQUES 
I. Reversible Permeabilization 






McNeil et al. (1984) 
Friedman et al. (1987) 
Nichols et al. (1989) 
Bar-Sagi & Feramisco (1986) 
Winicov & Gershengorn (1989) 
(b) Small Molecules (Mr< 2000) 
ATP4- Gomperts (1983) 
Dextran sulphate Kucera & Paulus (1982) 
II. Irreversible permeabilization 







Dunn & Holz (1983), Wilson & 
Kirshner (1983) 
Howell & Gomperts (1987) 
Lemons et al. (1988) 
Neher & Marty (1982) 
Martin (1989) 
(b) Small molecules (Mr< 2000) 
Staphyloccocal a-toxin 
High voltage shock 
Sendai virus 
Ahnert-Hilger et al. (1989) 
Baker & Knight (1983 
Gomperts et al. (1983) 
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acell cracking involves passing cells through a narrow 
aperture (typically< 4 µM) which produces a stable lesion 
in the plasma membrane (Martin, 1989) 
The advantage of reversible permeabilization is that, after 
manipulation of the intracellular milieu, the cells can be 
returned to their intact state. This is more physiological 
and allows prolonged survival of the cells after 
permeabilization (hours to days). However, reversibile 
permeabilization does not allow precise control of compounds 
which are sequestered (e.g. ca2+), or degraded (e.g. ATP and 
many proteins) by the cells. Conversely, cells 
permeabilized irreversibly survive for shorter periods 
(minutes to hours), and their intracellular milieu, being 
continuously accessible, can be precisely controlled. Since 
experiments on permeabilized cells seldom need to continue 
for more than one hour, irreversible permeabilization 
techniques are satisfactory for most purposes and, indeed, 
are far more widely used in exocytosis research. 
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The major advantage of permeabilization to large molecules 
is that it results in the leakage of many soluble 
intracellular proteins from the cell (Sarafian et al., 1987) 
and allows the introduction of large proteins., including 
antibodies, into the cell (Ali et al., 1989; Dekker et al., 
1989; Schweizer et al., 1989). After leaking proteins cells 
frequently lose their ability to secrete in response to 
stimuli such as ca2+ (Sarafian et al., 1987; Ali et al., 
.1989; Keffer and Gomperts, 1989; Martin and Walent, 1989a). 
Responsiveness to ca2+ can sometimes be reconstituted by 
adding back proteins, providing a convenient assay for 
purifying proteins essential for ca2+-stimulated exocytosis. 
This approach has already led to the purification of at 
least one protein, termed calekkrin (see Section 1.1.4.7), 
which appears to be essential for ca2+-stimulated exocytosis 
in "cracked" GH3 pituitary cells (Martin and Walent, 1989a; 
Martin and Walent, 1989b). 
Although the protein content of cells permeabilized to small 
molecules cannot be manipulated, an advantage of using these 
cells is that, since they do not lose soluble proteins, they 
are more both physiological as well as more stable (Koffer 
and Gomperts, 1989). Therefore, when experiments on 
regulated exocytosis do not require protein manipulation, 
permeabilization to small molecules is to be preferred. 
A major advantage of using the patch-pipette is that 
exocytosis can be monitored with excellent time resolution 
by measuring changes in plasma membrane electrical 
capacitance. Exocytosis results in the incorporation 
secretory vesicle membrane into the plasma membrane 
enlarging the plasma membrane area and therefore increasing 
the plasma membrane capacitance. This technique has been 
used successfully in a range of cell types (Neher and Marty , 
1982; Fernandez et al., 1984; Niisse and Lindau, 1988; Lim et 
al., 1990). 
1.2.3 a-Toxin Permeabilization 
In considering which permeabilization technique to use to 
study regulated exocytosis in the pituitary gonadotrope, we 
favoured selective permeabilization to small molecules since 
our experiments did not require protein manipulations. In 
addition, our experiments required continuous precise 
control of ca2+, ATP, and cAMP concentrations, which 
excluded permeabilization techniques which are necessarily 
transient (I(a) in Table 1). Although ATP4-, and dextran 
sulphate can be used for prolonged permeabilization [since 
reversal of their effect is under experimental control 
(Kucera and Paulus, 1982; Gomperts, 1983)], neither of these 
agents successfully permeabilized sheep anterior pituitary 
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cells (van der Merwe et al., 1989b; P.A. van der Merwe, J.S. 
Davidson, unpublished data). Of the three remaining methods 
which permeabilize cells to small molecules (II(b) in Table 
1), we favoured staphylococcal a-toxin since it can be used 
in substratum-attached cells [unlike high voltage shock 
(Baker and Knight, 1983)], and is easier to use than Sendai 
virus which must grown in the laboratory (Gomperts et al., 
1983). 
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Staphylococcus aureus a-toxin is a water-soluble monomeric 
protein exotoxin of Mr 34 000 which is secreted by most 
strains of Staphylococcus aureus (Bhakdi and Tranum-Jensen, 
1988). Monomeric a-toxin inserts into phospholipid bilayers 
(including biological membranes) after which it assembles 
into a transmembranous, hexameric, ring-shaped protein with 
a central pore of diameter 2-3 nM (Fiissle et al., 1981; 
Reichwein et al., 1987; Harshman et al., 1989). Membranes 
treated with a-toxin are rendered permeable to molecules 
with Mr up to 5 200 (Fiissle et al.,1981), and because 
monomeric a-toxin is too large to pass through such pores, 
only the plasma membrane is permeabilized. Once formed, a-
toxin pores are apparently stable for hours (Bhakdi and 
Tranum-Jensen, 1988; and this study) and do not close except 
in the presence of millimolar concentrations of divalent 
cations (Bashford et al., 1986). These properties make a-
toxin a suitable permeabilizing agent to investigate the 
mechanism of exocytosis as well as other cellular processes 
(Table 2). 
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TABLE 2 STUDIES USING CELLS PERMEABILIZED WITH 















Ahnert-Hilger et al. (1985) 
Bader et al. (1986) 
Schreizenmeier et al. (1988) 
Hohman (1988) 
Pancreatic islets Metz (1989) 
Anterior Pituitary van der Merwe et al. (1989a) 
Smooth muscle Kitizawa (1989) 
RINA2 & PC12 Fehr et al. (1989) 
1.3 STIMULUS-SECRETION COUPLING IN THE GONADOTROPE 
1.3.1 The GnRH Receptor 
GnRH is the primary regulator of gonadotropin secretion from 
anterior pituitary gonadotropes. The first step in 
gonadotrope stimulus-secretion coupling is the binding of 
GnRH to its cell surface receptor (for reviews see Conn et 
al., 1987; Hazum and Conn, 1988). The GnRH structural 
requirements for receptor binding and activation have been 
extensively studied and reviewed and will not be discussed 
further (Millar and King, 1987; Millar et al., 1989). The 
GnRH receptor has a monomeric Mr of 60 000 (Hazum and Conn, 
1988). There is evidence that GnRH-induced crosslinking of 
two receptors is important for receptor activation (Conn et 
al., 1987). Following activation, GnRH receptors form large-
scale clusters which are internalized and then either 
degraded or recycled to the cell surface (Hazum and 
Schvartz, 1987). Although neither large-scale cluster 
formation nor internalization are important for receptor 
activation (Conn et al., 1987), these processes probably 
mediate the decrease in cell-surface receptor number, called 
down-regulation, which occurs after prolonged GnRH 
stimulation. After prolonged exposure to GnRH, gonadotropes 
become unresponsive to GnRH, a process referred to as 
desensitization (Badger et al., 1983; King et al., 1986). 
Interestingly, receptor down-regulation appears to play 
little role in the developement of desensitization (Conn et 
al., 1987). Recent studies implicates GnRH-induced 
impairment of voltage-sensitive ca2+ channel activity in 
this process (Stojilkovic et al., 1989a). 
1.3.2 Generation of Second Messengers 
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GnRH stimulation of gonadotropes is followed by increases in 
cytosolic [ca2+]free (Chang et al., 1986; Limor et al., 
1987; Shanghold et al., 1988; Tasaka et al., 1988), 
activation of protein kinase C (PKC; Hirota et al., 1985; 
Naor et al., 1985; Strulovici et al., 1987), and the 
generation of cAMP (Borgeat et al., 1972) and arachidonic 
acid (Naor and Catt, 1981). There is some evidence that 
these effects of GnRH may be mediated through a signal-
transducing GTP binding protein or G protein (Andrews et 
al., 1986; Perrin et al., 1989), as is the case for many 
hormone receptors (Gilman, 1987). 
The increase in cytosolic [ca2+]free results both from the 
release of intracellular stored ca2+ and the entry of 
extracellular ca2+ (Shangold et al., 1988; Tasaka et al., 
1988). Release of stored ca2+ probably results from the 
action of inositol 1,4,5-trisphosphate (Guillemette et al., 
1987; Naor et al., 1988) which is one of two products 
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generated by the GnRH-stimulated action of 
phosphoinositidase C (PIC) on phosphatidylinositol 4,5 -
bisphosphate (Naor et al., 1986), the other being 
diacylglycerol (DAG; Andrews and Conn, 1986). Entry of 
extracellular ca2+ results from activation of 
dihydropyridine-inhibited, voltage-sensitive ca2+ channels 
as well as at least . one other class of ca2+ channels (Chang 
et al., 1986; Davidson et al., 1988; Smith et al., 1989). 
Activation of PKC probably results mainly from DAG 
generation, although ca2+ may also play a role (Hermon et 
al., 1986). 
GnRH may stimulate cAMP generation either directly or 
indirectly, through ca2+ or PKC, both of which regulate 
adenylate cyclase (Brostrom et al., 1982; Summers and 
Cronin, 1986; Minocherhomjee, et al., 1988). Arachidonic 
acid generation may result from (1) the action of 
phospholipase A2 on phospatidylcholine or 
phosphatidylethanolamine, or (2) through the sequential 
actions of PIC, DAG lipase, and monoacylglycerol lipase on 
phosphatidylinositol 4,5 - bisphosphate (Chang et al., 1988). 
As is the case with cAMP generation, arachidonic acid 
generation may be secondary to increased [ca2+]free and/or 
PKC activation (Burch et al., 1986; Burch and Axelrod, 1987; 
Feinstein and Halenda, 1988; Churcher et al., 1990) . 
Arachidonic acid may exert its effect on gonadotropin 
secretion after conversion to leukotrienes by 5- lipoxygenase 
(Samuelsson et al., 1987; Hulting et al . , 1985; Naor et al., 
1985a). 
Elucidating the precise mechanisms by which second 
messengers are generated in response to agonists such as 
GnRH is complicated by the fact that numerous interactions 
between second messenger pathways exist, some of which have 
been described above. For example, an increase in cytosolic 
[ca2+]free could cause activation of PKC as well as 
increased cAMP and arachidonic acid generation, thus 
accounting for all the observed effects of GnRH on second 
messengers. 
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1.3.3 Regulation of gonadotropin exocytosis 
As is the case in many other secretory cells (Berridge, 
1985; Baker and Knight, 1986; Rink and Knight, 1988), ca2+ 
appears to be the dominant regulator of gonadotropin 
exocytosis (for reviews see Conn et al., 1987; Huckle and 
Conn, 1988; Stojilkovic et al., 1989b). Roles for cAMP, PKC 
and arachidonic acid and its metabolites have been proposed 
on the basis of studies in intact cells (Borgeat et al., 
1972; Smith and Vale, 1980; Naor et al. 1985a). A pitfall of 
these studies is that cAMP (Luini et al., 1985), activators 
of PKC (Albert et al., 1987; Stojilkovic et al., 1988a; 
Restrepo et al., 1989; Yada et al., 1989), and arachidonic 
acid (Kolesnick et al., 1984) may all induce increases in 
cytosolic [ca2+]free, which itself stimulates LH exocytosis. 
For this and other reasons the role of these second 
messengers is controversial and will be discussed further in 
Section 3. The precise mechanism by which ca2+ stimulates LH 
exocytosis is not known. Clearly, any of the calcium binding 
proteins wich have been implicated in exocytosis are 
potential targets for calcium (see Section 1.2). Recently 
attention has focused on calmodulin and PKC as possible 
mediators of ca2+-stimulated LH exocytosis. The role of 
these proteins in LH exocytosis is discussed further in 
Section 4. 
2 MATERIALS AND METHODS 
2.1 MATERIALS 
Purified, lyophilized Staphylococcus aureus a-toxin was 
obtained from Dr. Sucharit Bhakdi (Institute of Medical 
Microbiology, Justus-Liebig University, Giessen, Germany) 
and was stored at -20°C. Stock aliquots of a-toxin in 
solution (0.5 mg/ml) were stored at -20°C for up to 6 months 
with no loss of activity as determined by monitoring induced 
2-deoxy[3H]glucose efflux (see Section 2.5). Myo-[2-
3H]inositol (10-20 Ci/mmol), [a-14c]adenosine (50-60 
mCi/mmol), [5,6-3H]uridine (35-50 Ci/mmol), 2-deoxy-D[2,6-
3H]glucose (30-60 Ci/mmol), and I125 (10-15 mCi/µg) were 
obtained from The Radiochemical Centre (Amersham, Bucks., 
UK). ATPyS, GDPBS, GTPyS, GMPPNP, and staurosporine were 
supplied by Boehringer-Mannheim Biochemicals (Mannheim, 
Germany). Staurosporine was dissolved in Me2SO at 1 mM (w/v) 
and stored at 4°C. Ovine LH (NIADDK-oLH-I-3) and ovine LH 
antiserum (NIADDK-anti-oLH-1) were kindly provided by the 
National Institute of Diabetes and Digestive and Kidney 
Diseases (NIDDK), U.S.A .. Mammalian GnRH was synthesized by 
Dr R.C. deL. Milton, Department of Chemical Pathology, 
University of Cape Town Medical School. All other chemicals 
were from Sigma Chemical Co. (St. Louis, MO, U.S.A.). 
2.2 CELL CULTURE 
Pituitaries were removed from 6-12 month old castrated male 
sheep within 30 minutes of slaughter at the Cape Town 
municipal abattoir and immediately transported to the 
laboratory in ice-cold Minimal Essential Medium (MEM; Gibco, 
Paisley, Scotland) containing 20 mM HEPES (pH 7.4) and 
amphotericin B (2.5 mg/L). Within 1 hour the anterior 
pituitaries were dissected free from the capsule and 
posterior pituitary, minced, and incubated in collagenase 
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solution [collagenase 0.9% (w/v) (155 U/mg, Worthington 
Biochemical Corp., Freehold, NJ) and 18 mg/L 
deoxyribonuclease (Miles Laboratories, Elkhardt, IN) in 
buffer B] for 2-3 hat 37°C. Buffer B comprised(~): NaCl, 
137; KCl, 5; Na2HP04, 0.7; HEPES, 25 (pH 7.2); CaCl2, 0.36; 
glucose, 10; and 1% (w/v) BSA (fatty acid free, Pentex 
fraction V, Miles Laboratories). Undigested material was 
filtered out with nylon gauze and the suspension centrifuged 
at 400 x g for 10 min at 20°C. The pellet was resuspended in 
buffer B, centrifuged again, and then resuspended in MEM 
containing NaHC03 (1 g/L), 10% (v/v) fetal calf serum 
(Gibco, Grand Island, NY), penicillin (60 mg/L), and 
streptomycin (100 mg/L). The suspension was drawn twice 
through a 19-gauge needle, filtered through nylon gauze, and 
dispensed at a density of 4 x 105 cells/well in 12-well cell 
culture plate (Nunc, Copenhagen, Denmark). All experiments 
were performed after 48 h of culture in 5% C02/95% air, at 
which time the pituitary cells were firmly attached to the 
substratum. 
2.3 CELL PERMEABILIZATION AND STIMULATION 
An outline of the basic protocol which was adopted for most 
experiments in this thesis is shown in Table 3. 
TABLE 3 BASIC PROTOCOL FOR PERMEABILIZED CELL EXPERIMENTS 
Procedure Buffer Time Temperature 
------------------------------------------------------------
1 . Washing I 15 min 37°c 
2. Permeabilization IC 10 min 37°c 
3. Cooling IC 10 min 0°C 
4. Equilibration IC 30 min 0°C 
5. Stimulation IC 10-30 min 37°c 
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Adherent anterior pituitary cells were washed twice (once 
briefly, once for 10 min) with buffer I and then once (for 5 
min) with ca2+_free buffer I at 37°C on a slowly rotating 
shaker. Buffer I comprised (mM): NaCl, 140; KCl, 4; MgCl2, 
1; CaCl2, 1; glucose 8.3; HEPES, 20 (pH 7.4); phenol red, 6 
mg/L; and 0.1% (w/v) BSA. The cells were then permeabilized 
by incubation in buffer IC (0.3 ml/well) containing 3 µg/ml 
a-toxin, 0.5 mM EGTA, 6.5 mM MgCl2, and 6 mM Na2ATP for 10 
min at 37C on a slowly rotating shaker. Buffer IC comprised 
(mM): Na propionate, 140; KCl, 4; NaPIPES, 25 (pH 6.6); 
phenol red, 6 mg/L; and 0.1% (w/v) BSA. A pH of 6.6 was 
chosen because it allows buffering of free ca2+ in the 
concentration range 0.1 to 30 µMusing EGTA (see Figure 1). 
Buffers at this pH are widely used in experiments on 
permeabilized cells (Knight and Baker, 1982; Wilson and 
Kirshner, 1983; Dunn and Holz, 1983; Knight et al., 1984; 
Vallar et al., 1987; Luini and De Matteis, 1988). After 10 
min the cell culture plates were cooled by placing them 
directly on ice in a 4°C refrigerator for 10 min, after 
which time the medium temperature was less than 4°C. The 
permeabilization medium was aspirated and replaced with ice-
cold stimulation buffer (0.3-0.5 ml/well). Stimulation 
buffer comprised IC buffer with MgCl2 (6.5 mM), Na2ATP (6 
41 
mM) and 10 or 30 mM CaEGTA buffer with the indicated 
[ca2+]free (prepared as described in Section 2.6). In all 
experiments additional nucleotides were added with equimolar 
MgCl2 unless otherwise indicated. After equilibration on ice 
for the indicated time (usually 30 minutes), LH exocytosis 
was initiated by warming to 37°C in a waterbath or by 
replacement with identical medium at 37°C and transferring 
the cell culture plates to a 37°C incubator. After the 
indicated stimulation time (10-30 min), the medium was 
removed for LH determination. Detached cells were removed 
from all stimulation media by centrifugation (400 x g, 8 
min, 4°C), and the supernatant was stored at -20°C until LH 
determination (see Section 2.4). 
This basic protocol was modified in some experiments as 
follows: 
(a) In experiments examining staurosporine inhibitory 
effects (Section 4), cells were permeabilized for 20 min. 
Staurosporine was added at the indicated concentration after 
5 min of permeabilization and was present until the end of 
the experiment. This allowed a 15 min pre-incubation with 
staurosporine at 37°C. 
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(b) In all experiments examining the effects of nucleotides, 
ATP was omitted during the permeabilization step and was 
included in the equilibration steps only when indicated in 
the figure legend. When ATP was omitted MgCl2 2 mM was 
present instead of 6.5 mM. 
(c) In experiments where guanine nucleotide inhibitory 
effects were examined (Section 5.2.2), an additional pre-
incubation step at 37°C was introduced (see Figure 36). 
Cells were equilibrated for 30 min at 0°C in the presence of 
guanine nucleotides and then were warmed to 37°C and pre-
incubated for a further 30 min in the same medium. After 
preincubation the medium was removed and the cells were 
stimulated for 30 min in stimulation buffer (containing 6.5 
mM MgCl2 and 6 mM Na2ATP). 
LH released is expressed as a percentage of the total 
cellular LH present at the beginning of the stimulation 
period. Total cellular LH was measured after solubilizing 
the cells in Nonidet NP40 (1%, v/v). The average cellular LH 
content calculated from a large number of experiments was 
680 ± 60 ng/well (mean± SEM, n = 38) which is the 
equivalent of 1.7 ± 0.2 µg per 106 cells or 16.4 ± 1 .5 
µg/pituitary. 
2.4 LH DETERMINATION 
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Luteinizing hormone was measured by radioimmunoassay using 
antiserum (NIADDK-anti-oLH-1) and ovine LH (NIADDK-QLH-I-3) 
kindly provided by the NIDDK and used as recommended. Ovine 
LH antiserum was used at a final titre of 1 : 2 000 000. LH 
was iodinated by Chloramine-T method and free r125 was 
separated from r125_LH on a Sephadex G- 100 (Pharmacia, 
Uppsala, Sweden) column. Radioactivity determinations were 
performed using a Crystal gamma counter (Packard, United 
Technologies). The antiserum-bound LH was separated from 
unbound LH by second antibody attached to cellulose (Sac-Cel 
RD70, Wellcome Reagents Limited, Beckenham, England). After 
iodination, the proportion of radioactivity in the r125_LH 
preparation which bound the LH antiserum (Bo/T x 100; Bo= 
radiolabel which bound the LH antiserum in the absence of 
unlabelled LH; T = total radiolabel) was typically 40-50 % 
and a particular preparation of r125_LH was used until this 
value fell below 25 percent. Non-specific binding (N/T x 
100; N = radioactivity which remained in the tube in the 
absence of LH antiserum) was routinely< 5 percent. A 
standard curve was generated using unlabelled ovine LH (NIH-
LH-S18) and fitted by the logistic method. The useful range 
of the assay (B/Bo x 100 between 80% and 20%; B = antiserum-
bound radioactivity in the presence of unlabelled LH) was 
typically 0.4 to 8 ng/mL ovine LH. Intraassay and interassay 
coefficients of variation were less than 5% and 8% 
respectively. 
2.5 MEASUREMENT OF PLASMA MEMBRANE PERMEABILITY 
Adherent cells were incubated for 1 hat 37°C with 2-
deoxy[3H]glucose (0.4 µCi/ml) in glucose-free buffer I (0.75 
ml/well). Cells were then washed 7 times (3 times briefly 
and 4 times for 5 min on a slowly rotating shaker) in buffer 
I (1 ml/well). The remaining radioactivity represents 
intracellularly trapped, membrane-impermeant, phosphorylated 
metabolites of 2-deoxy[3H]glucose. The buffer was then 
replaced with buffer IC (1 ml/well) containing EGTA (0.5 
mM), MgCl2 (1 mM) and the indicated additions, and the 
radioactivity appearing in the medium was determined on a 
Beckman LS 3801 liquid scintillation counter after 
dissolving the medium in scintillation fluid (Instagel, 
Packard). Total cellular radioactivity was determined after 
solubilizing cells with 0.5% (w/v) sodium dodecyl sulfate. 
Lactate dehydrogenase efflux was measured under the same 
conditions. Lactate dehydrogenase activity was assayed by 
spectrophotometric monitoring of NADH disappearance in the 
presence of excess pyruvate. LDH assays were performed on a 
Centrifchem System 800 centrifugal analyser (Union, 
Cambridge). 
Efflux of [14c]adenosine- and [3H]uridine- labelled pools 
was measured in the same way as 2-deoxy[3H]glucose except 
that the effluxed label is expressed as a percentage of 
total trichloroacetic acid(TCA)-soluble cellular 
radioactivity. Total TCA-soluble radioactivity was 
determined by washing cells twice in 1 ml of 5% TCA at 4°C 
on a rotating shaker for 5 min. The wash medium was pooled 
and insoluble material was removed by centrifugation at 1000 
x g (0°C, 10 min). The radioactivity in the supernatant was 
determined by liquid scintillation counting after adjusting 
the pH to 7 with 0.5 M NaOH. 
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2.6 CaEGTA AND BaEGTA BUFFERS 
2.6.1 Caculation of CaEGTA and BaEGTA ratios 
The indicated [ca2+]free and [Ba2+]free were obtained using 
EGTA buffers with varying ca2+ to EGTA and Ba2+ to EGTA 
ratios (Figure 1 and Table 4). The required ratios were 
calculated using a computer program written by us which used 
equations given in Fabiato and Fabiato (1979) (see 
Appendix). 
The apparent metal-ligand stability constants for ATP and 
EGTA which were used in the program (Table 5) were 
calculated from absolute stabilitity constants compiled by 
Fabiato (1981) which were adjusted for use at 37°C using 
enthalpy changes as described by Martell and Smith (1976) 
(see Appendix). In medium containing nucleotide 
triphosphates, sufficient MgCl2 was always added to maintain 
free Mg2+ at 1-2 mM, calculated using the computer program. 
The stability constants for ca2+ and Mg2+ binding to non-ATP 
nucleotides were assumed to be similar to those for ATP. 
Neither nucleotides nor MgCl2 (at the concentrations used 
experimentally) could have altered the calculated pCa by 
more than 0.04. Since the pH critically affects the 
[ca2+]free and [Ba2+]free at a particular CaEGTA or BaEGTA 
ratio (Figure 1), all nucleotide triphosphate stock 
solutions were prepared at pH 6.6 and the effect of all test 
substances on the pH of the buffer was checked. In 
experiments performed at pH 7.1 (insets to Figures 9, 14, 
and 33) the pH of the final stimulation media was adjusted 
to 7.1 with NaOH. 
TABLE 4 CALCULATED CaEGTA AND BaEGTA RATIOS USED TO OBTAIN 
SPECIFIED [ca2+]free AND [Ba2+]free 
pH 6.6 pH 7.1 
(a) pea Ca/EGTA Ratios* 
9 0.005 
8 0.005 0.047 
7 0.051 0.332 
6.5 0. 145 0. 611 
6 0.349 0.832 
5.5 0.629 0.940 
5 0.845 0.981 
4.5 0.947 
(b) pBa Ba/EGTA Ratios* 
4.5 0.043 




*These ratios were calculated assuming the following final 
total concentrations (mM): EGTA, 30; Na+, 165, K+, 4, MgC12, 
6.5, Na2ATP 6. However, these ratios vary less than 1 % for 
total EGTA concentrations ranging from 5 to 30 mM. 
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TABLE 5 CACULATED APPARENT STABILITY CONSTANTS FOR 
TEMPERATURE 37°C AND IONIC STRENGTH 0.16 M 
Apparent Stability Constant (M-1) 
Ligand Cation 
pH 6.6 pH 7.1 
EGTA Ca2+ 546320 5370716 
EGTA Ba2+ 1401 13138 
EGTA Mg2+ 20 82 
ATP Ca2+ 2095 4340 
ATP Ba2+ 358 731 
ATP Mg2+ 7737 15678 
ATP Na+ 5 6 
ATP K+ 2 4 
2.6.2 Preparation of CaEGTA and BaEGTA buffers 
Because of the uncertain purity of EGTA (Miller & Smith, 
1984) accurate Ca:EGTA ratios could not be determined by 
mixed weighed quantities of CaCl2 and EGTA. Instead, CaEGTA 
buffers of varying Ca:EGTA ratios were prepared by mixing a 
stock solution of ca2+-free EGTA with a stock solution of 
CaEGTA which had a ca2+ to EGTA ratio of precisely 1:1 
[CaEGTA(1:1)]. Since both stocks were prepared from the same 
batch of EGTA they had nearly identical EGTA concentrations 
(160 mM assuming 97% EGTA purity). Precise CaEGTA ratios 
were then easily obtained by accurate mixing of these stocks 
in different ratios. An additional advantage of this method 
is that if the pH each stock is adjusted to 6.6, the pH of 
the mixed stocks is invariably also 6.6 irrespective of 
final Ca:EGTA ratio. 
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CaEGTA(1 :1) was prepared by end-point titration with 
Ca.oxalate precipitation as the end-point (modified from 
Tatham and Gomperts, 1987; Miller and Smith, 1984). Briefly, 
CaEGTA at a ratio of approximately 0.9:1 was prepared by 
mixing weighed quantitities of CaC03 (180 mM) and EGTA (200 
mM) in water and stirring at 80°C until dissolved. Potassium 
oxalate (final concentration 50 mM) was added to precisely 
25 ml of this CaEGTA(0.9:1) solution. After bringing the pH 
to> 11 with NaOH, CaCl2 was added from a 0.5 M stock 
solution in 0.02 ml aliquots using a precision burette while 
stirring continuously. CaEGTA was assumed to be 1:1 when, 
after adding 0.02 ml of CaCl2, the solution remained cloudy 
for> 1 min, indicating Ca.oxalate precipitation. With 
repeat titrations the volume of CaCl2 required for 
Ca.oxalate precipitation varied less than 2%. The mean of 
three determinations was used for further calculations. The 
appropriate amount of the same 0.5 M CaCl2 stock was then 
added from the same burette to precisely 200 ml of CaEGTA 
(0.9:1) to give CaEGTA(1:1). This was brought to pH 6.6 with 
NaOH and the volume increased to 250 mM to give 160 mM 
CaEGTA(1:1). 
BaEGTA buffers were prepared in the same way except that 
BaEGTA(1:1) was prepared by mixing weighed quantities of 
BaCl2 and EGTA. [Ba2+]free concentrations are therefore less 
accurate than the [ca2+]free concentrations. 
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2.6.3 Measurement of [ca2+]free by ca2+ electrode 
The [ca2+]free of CaEGTA buffers (at the final concentration 
used experimentally) were checked with a ca2+ selective 
electrode (Radiometer Selectrode F2112Ca). All 
determinations were performed at 37°C in Buffer E 
[comprising (mM): NaCl, 140; KC!, 4; NaPIPES, 25 (pH 6.6)] 
which resembles Buffer IC but differs in that (1) NaCl is 
used instead of Na propionate, since propionate binds ca2+ 
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weakly and (2) phenol red and BSA are not included since 
they shorten the life of the electrode membrane. Although 
weak, the binding of propionate to ca2+ interferes with the 
ca2+ standards since these are unbuffered and the ca2+ 
concentrations are high. ca2+ standards consisted of CaCl2 
in Buffer E, and were calibrated by atomic absorbtion 
spectrophotometry using a Varian Spectra AA10. Semi-
logarithmic plots of the electrode potential produced by the 
ca2+ standards (pea 2, 2.5, 3, 3.5, 4) in Buffer E were 
consistently linear with a slope of 30 ± 1 mV/pCa unit (n = 
8). The [ca2+]free produced by the CaEGTA buffers (pea 4 to 
pCa 6.5) diluted in buffer E were checked against the 
extrapolated standard line. The measured [ca2+]free produced 
by the prepared CaEGTA buffers varied less than 0.1 pCa unit 
from the expected pea. Below pCa 6.5 the electrode response 
was non-linear and so the [ca2+]free could not be directly 
checked at these low concentrations. 
2.7 ASSESSMENT OF NUCLEOTIDE PURITY 
Nucleotides were kindly analysed for purity by Dr. Peter 
Cole on a Spectra Physics 3500 HPLC system with a Hi Chrom 
APSHYP2537 anion exchange column, using a linear gradient of 
potassium phosphate from 50 mM, pH 2.5 to 500 mM, pH 3.8. 
2.8 STIMULATION OF INTACT CELLS AND CELLULAR CAMP 
DETERMINATION 
Attached cells were washed four times (twice briefly and 
then twice for 10 min) with Buffer I followed by stimulation 
in buffer I for 60 minutes at 37°C. The medium was 
collected and processed for LH determination as described in 
sections 2.3 and 2.4. For cAMP extraction cells were 
dissolved in 0.4 ml 0.1 M HCl which was neutralised with 0.1 
ml 100 mM Na-Tris (pH 13) before cAMP determination by 
competitive binding assay (Amersham kit no. TKR 342) 
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according to the kit instructions. The assay principle is 
the competition by cold cAMP with [8-3H]cAMP for binding to 
a specific cAMP-binding protein. Free [8-3H]cAMP is removed 
by coated charcoal. The unknown [cAMP] is calculated with 
reference to a standard curve generated with cAMP standards. 
The intraassay coefficient of variation was less than 5 
~ercent. 
2.9 DATA PRESENTATION 
Data points and error bars represent the mean and the SEM of 
triplicate or the mean and range of duplicate 
determinations. The absence of error bars indicates that the 
error was smaller than the dimensions of the symbol. ANOVA 
and the modified Student's t-test were used to test 
statistical significance where indicated. 
3 PERMEABILIZATION OF CELLS AND CHARACTERIZATION OF 
CALCIUM-. PHORBOL ESTER-. AND CAMP-REGULATED LH EXOCYTOSIS 
3.1 INTRODUCTION 
Studies in intact pituitary gonadotropes have implicated a 
rise in cytosolic [ca2+]free as the major intracellular 
mechanism mediating GnRH-stimulated LH exocytosis (see 
Section 1.3). The ability of raised cytosolic [ca2+]free to 
stimulate LH exocytosis has been studied in intact cells 
using ca2+ ionophores (Hopkins and Walker, 1978; Conn et 
al., 1979b). It is not possible, however, to achieve 
sustained and accurately defined [ca2+]free using this 
method. To determine the precise ca2+ requirements for LH 
exocytosis, direct access to the cytosol is required. 
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Although GnRH clearly activates PKC (Hirota et al., 1985; 
Naor et al., 1985b; Strulovici et al., 1987) and activators 
of PKC stimulate LH exocytosis in intact cells (Smith and 
Vale, 1980), the role of PKC in mediating GnRH-stimulated LH 
exocytosis remains controversial (McArdle et al., 1987; 
Stojilkovic et al., 1988a,b; Conn, 1989). One problem with 
studies in intact cells is that activators of PKC can 
stimulate changes in cytosolic [Ca2+]free (Albert et al., 
1987; Stojilkovic et al., 1988a; Restrepo et al., 1989; Yada 
et al., 1989), presumably through effects of PKC on ca2+_ 
regulating proteins (Nishizuka, 1986; Yamaguchi et al., 
1987; Smallwood et al., 1988; Yada et al., 1989; Yoshida and 
Nachmias, 1989). As a result, experiments in intact cells 
leave open the possibility that effects of PKC activation on 
LH exocytosis are secondary to increases in cytosolic 
[Ca2+lfree· 
As is the case with PKC, the role of cAMP in mediating GnRH-
stimulated LH exocytosis is controversial. Early reports 
claiming a second messenger role for cAMP (Borgeat et al., 
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1972; Kaneko et al., 1973; Makino, 1973; Bonney and 
Cunningham, 1977; Kercret et al., 1977) were not confirmed 
in subsequent work (Naor et al., 1975; Conn et al., 1979a; 
Sen and Menon, 1979; Benoist et al., 1981). Since all these 
studies were performed in intact cells, the effects of cAMP 
on LH exocytosis were examined using high concentrations of 
membrane-permeable cAMP analogues or by activating adenylate 
cyclase with forskolin. These approaches have pitfalls since 
cAMP analogues are used at concentrations at which they 
interact with the GnRH receptor (Smith et al., 1982; Capponi 
et al., 1984) while forskolin is not entirely specific 
(Hoshi et al., 1988). More importantly, cAMP can activate 
voltage sensitive plasma membrane ca2+ channels in 
gonadotropes (Mason and Sikdar, 1989) and other cell types 
(Osterrieder et al., 1982; Curtiss and Catterall, 1985; 
Armstrong and Eckert, 1987) and thereby stimulate an 
increase in cytosolic [ca2+]free (Luini et al., 1985; Leong, 
1988; Lau and Bourdau, 1989). This could explain the finding 
that forskolin-stimulated LH secretion is dependent on 
extracellular ca2+ and inhibited by voltage-sensitive ca2+ 
channel blockers (Cronin et al., 1984). 
By utilizing permeabilized cells, several of the pitfalls of 
previous studies can be bypassed because the cytosolic 
[Ca2+]free can be clamped at the desired level using ca2+ 
buffers and furthermore, membrane-impermeable agents such as 
cAMP can be introduced directly into the cell at known 
concentrations. An additional advantage of permeabilized 
cells is that the requirements of exocytosis for endogenous 
small molecules (such as ATP) may be determined. 
In this section the permeabilization procedure is described, 
the regulation of LH exocytosis by ca2+, PKC, and cAMP is 
characterized, and the role of ATP in regulated exocytosis 
is investigated. Although exocytosis has been investigated 
· in permeabilized cells of the pituitary-derived GH3 and 
AtT20 tumor cell lines (Ronning and Martin, 1986a; Luini and 
De Matteis, 1988), this is the first study on the regulation 
of exocytosis in permeabilized primary anterior pituitary 
cells. 
3.2 RESULTS 
3.2.1 a-Toxin permeabilization 
Permeabilization of primary sheep anterior pituitary cells 
was monitored using 2-deoxy[3H]glucose. Plasma membrane-
impermeant phosphorylated metabolites of 2-deoxy[3H]glucose 
(Mr 250) effluxed very slowly from intact cells, whereas 
after addit~on of 3-30 µg/ml staphylococcal a-toxin, 85% of 
trapped 2-deoxy[3H]glucose metabolites was released within 
18 minutes (Figure 2). Increasing the a-toxin above 3 µg/ml 
did not significantly increase the final extent or the 
maximal rate of 2-deoxy[3H]glucose efflux but did shorten 
the lag time before onset of efflux (Figure 2). When the 
efflux of phosphorylated metabolites of c·14c]adenosine and 
[3H]uridine (which comprise mostly [14c]ATP and [3H]UTP, 
respectively) were used to monitor permeabilization, a-toxin 
(3 µg/ml) evoked efflux of 85% (Figure 19) and 80% (Figure 
3), respectively, of total trichloroacetic acid-soluble 
cellular label within 20 minutes. Under the same conditions 
a-toxin caused efflux of less than 2% of cellular lactate 
dehydrogenase (Mr 134 000, Figure 3), indicating that the 
cells are rendered selectively permeable to small molecules 
including nucleotide triphosphates. In cells exposed to a-
toxin (3 µg/ml) for the initial 5 minutes only, the rate and 
extent of efflux of 2-deoxy[3H]glucose label was as great as 
during continuous exposure, indicating that permeabilization 
was complete within 5 minutes (Figure 4). The efflux rate of 
2-deoxy[3H]glucose label (half-time 5-10 minutes) is 
therefore probably limited by diffusional constraints 
(limited size and number of pores) rather than the rate of 
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pore formation. Permeabilization does not occur at 0°C 
(Table 6). Decreasing the temperature from 37°C to 0°C after 
five minutes caused only a small (15%) decrease in the 
efflux of label (Table 6). This lack of temperature 
dependence suggests that efflux occurs by simple diffusion 
once permeabilization has occured and confirms that 
permeabilization is complete within 5 min. None of the 
agents used in subsequent experiments on permeabilized cells 
affected a-toxin permeabilization as monitored by efflux of 
2-deoxy[3H]glucose label (Table 6). 
3.2.2 ca2+ dependence for LH Exocytosis 
A five-step protocol was employed for most experiments on LH 
exocytosis (Table 3). After (1) washing, cells were (2) 
permeabilized at 37°C in low ca2+ medium. The cells were 
then (3) cooled, after which they were (4) equilibrated with 
stimulation medium containing defined buffered [ca2+]free at 
0°C for at least 30 minutes. This was designed to allow 
adequate time for equilibration of small ~xtracellular 
molecules such as CaEGTA (Figure 7B) and ATP (Figures 19 
and 20) with the cytoplasm. Permeabilization and 
equilibration were performed separately because a-toxin 
permeabilization is strongly retarded at low temperatures 
(Table 6). After equilibration, exocytosis was (5) 
stimulated by increasing the stimulation medium temperature 
to 37°C. Under these conditions minimal LH release occurred 
during the permeabilization (1 ± 0.2 %, n = 2) and 
equilibration periods (Table 7). 
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TABLE 6 THE EFFECTS OF VARIOUS AGENTS ON a-TOXIN 
PERMEABILIZATION 
Permeabilization was monitored by measuring efflux of 
intracellular 2-deoxy[3H]glucose metabolites over 20 min. 
Experiments were conducted in buffer IC with EGTA 0.5 mM and 
MgCl2 1 mM except when ca2+ and Ba2+ were tested (where EGTA 
was 30 mM) or when ATP was tested (where MgCl2 was 6.5 mM). 
Addition 2-deoxy[3H]glucose efflux(% of control)a 
control 100 
no a-toxin 14 ± 1 
31°c (5 min) then 0°C (15 min)b 85 ± 1 
oocc 4 ± 1 
0°C (no a-toxin)C 3 ± 1 
pCa 8 99 ± 1 
pCa 6 99 ± 1 
pCa 4 1 oo· ± 2 
pBa 2.5 104 ± 4 
cAMP (300 µM) 105 ± 4 
IBMX (0.5 mM) 1 01 ± 6 
ATP ( 6 mM) 97 ± 1 
GTPyS ( 1 00 µM) 98 ± 3 
trifluoperazine ( 30 µM) 102 ± 1 
staurosporine ( 1 µM) 99 ± 1 
aThe control value represents permeabilization by 3 µg/ml a-
toxin at 37°C without additions and is normalized to 100 %. 
The mean and range duplicate determinations are shown. 
bAfter permeabilization for 5 min at 37°C, the medium was 
replaced with identical medium at 0°C and incubated for a 
further 15 min on ice. Total efflux over 20 min is shown. 
CAfter washing, permeabilization medium was added at 0°C. 
TABLE 7 LH RELEASE DURING THE EQUILIBRATION PERIOD 
Permeabilized cells were equilibrated at 0°e in stimulation 
buffer with eaEGTA 30 rnM and the indicated [ea2+]free for 30 




LH released (%)a 
0.7 ± 0.2 
1 . 1 ± 0. 3b 
aMean and SEM of three independent experiments. 
bNot significantly different from pea 7 (p > 0.05). 
When permeabilized cells which had been equilibrated with 
eaEGTA (pea 5) and MgATP-containing medium were warmed to 
37°e, rapid exocytosis of LH was initiated (Figure 5). 
Exocytosis was maximal during the first 3 minutes and 
declined to basal levels after 12 minutes (Figure 5). This 
decline could result either from the development of 
refractoriness to maintained high [ea2+]free or, 
alternatively, from a lowering of cytosolic [ea2+]free by 
cellular ea2+ sequestration mechanisms activated by warming 
to 37°e. The latter possibility is unlikely since exocytosis 
of LH at sub-maximal free ea2+ concentrations (pea 5.5) 
continued after 12 minutes (Figure 5). Maximal LH 
exocytosis occurred at pea 5.25-4.75 (Figure 6) with half-
maximal exocytosis at pea 5.7-5.4 (Figure 6, Table 8). 
Although the ea2+ Ee50 for LH exocytosis was highly 
reproducible, the extent of LH release was quite variable 
between experiments (Table 8). For this reason, instead of 
combining results from different experiments, results of 
representative experiments are shown. 
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TABLE 8 ca2+_sTIMULATED LH EXOCYTOSIS 
All experiments were performed as described in the legend to 
Figure 6. The EC5os for ca2+ were deduced by visual 
inspection of the ca2+ dose-response curve. 
Experiment ca2+ EC5o (pCa) Maximal LH Exocytosis (%) 
1 . 5.6 27 
2. 5.7 12 
3. 5.4 21 
4. 5.4 20 
5. 5.5 26 
6. 5.7 46 
7. 5.5 18 
8. 5.5 20 
9. 5.4 19 
10. 5.4 32 
11 . 5.7 1·2 
12. 5.5 29 
13. 5.5 13 
14. 5.6 22 
Mean(± SEM) 5.5 (± 0.1) 23 (±. 3) 
A consistent finding in experiments wa~ an inhibition of 
exocytosis at [ca2+Jfree above pCa 4.5 (Figure 6). 
Permeabilization was unaffected by varying the ca2+ 
concentration over the range pCa 8 to 4 (Table 6), 
indicating that the decrease in exocytosis at high 
[ca2+Jfree is not due to closure of the pores. Basal LH 
exocytosis from intact cells was unaffected by varying the 
[ca2+Jfree from pCa 7 to 4 (Figure 6). 
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High total EGTA concentrations were necessary to achieve 
adequate ca2+ buffering. When the EGTA concentration was 
varied while keeping the [ca2+]free constant (verified by 
ca2+ electrode), exocytosis was dependent on EGTA 
concentration up to 20 mM (Figure 7A). In addition, at low 
[EGTA] the apparent ca2+-dependence of exocytosis was 
markedly shifted towards higher ca2+ concentrations (Figure 
8). This indicates that ca2+ buffering is inadequate when 
EGTA concentrations are below 20 mM and that, as a result, 
the cytosolic [ca2+]free is lowered by cellular ca2+ 
sequestration mechanisms. Under conditions of inadequate 
ca2+ buffering the true ca2+ dependence of exocytosis cannot 
be determined. Furthermore, with weak buffering any 
manipulation which altered the rate of ca2+ sequestration 
would be likely to alter the cytosolic [ca2+]free· 
Consequently, CaEGTA buffers were used at 30 mM (EGTA 
concentration) in all experiments in which the [ca2+]free 
was different to resting values (pCa 7). Increasing the 
equilibration period from 10 to 30 minutes at a suboptimal 
EGTA concentration (10 mM) did not increase LH exocytosis 
(Figure 7B), indicating that the 30 minute equilibration 
period used allows ample time for equilibration of CaEGTA. 
3.2.3 PKC activation and LH exocytosis 
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The PKC-activating phorbol ester PMA stimulated LH 
exocytosis to a similar extent at all [ca2+]free without 
significantly modifying the ca2+ sensitivity of LH 
exocytosis (Figures 9, 26 and 27). PMA was able to stimulate 
LH exocytosis at ca2+ concentrations as low as pCa 8, 
suggesting that ca2+-independent exocytosis is possible 
(Figure 9). The stability constant for Ca-EGTA binding is 
such that it is not possible to accurately decrease the 
[ca2+]free below pCa 8 using EGTA at pH 6.6 (Figure 1, Table 
4). The experiment was therefore performed at pH 7.1 at 
which the tighter binding of ca2+ to EGTA permits lowering 
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of the [Ca2+Jfree to pCa 9 (Figure 9, inset). PMA was able 
to stimulate exocytosis even at this very low [ca2+Jfree, 
confirming that PKC-stimulated ca2+-independent exocytosis 
can occur. In a time course, maximal PMA-stimulated LH 
exocytosis occurred in the first 3 minutes followed by a 
period of slow release which continued for at least 15 
minutes (Figure 10). PMA-stimulated LH exocytosis was 
maximal at 100-300 nM and half-maximal at 20-50 nM (Figures 
16 and 34). 
TABLE 9 EFFECT OF cAMP ON LH EXOCYTOSIS IN INTACT CELLS 
The standard protocol was used (Table 3) except that a-toxin 
was omitted from the permeabilization medium for experiments 
on intact cells. Cells were then equilibrated in stimulation 
buffer for 30 min at 0°C with CaEGTA 10 mM (pea 7) and the 
indicated additions. Exocytosis was initiated by replacing 
with identical medium at 37°C and LH released after 10 min 
was determined. 
LH released (%)a 
(a) Permeabilized Cells 
control 3.2 ± 0.7 
cAMP 300 µM 8.3 ± 0.1 
(b) Intact Cells 
control 3.7 ± 0.5 
cAMP 300 µM 2.3 ± 0.4 
aMean ± range (n = 2) 
3.2.4. CAMP-stimulated LH exocytosis 
At resting [ca2+]free (pCa 7) cAMP stimulated LH exocytosis 
with half-maximal LH release at 30 µM cAMP (Figure 11). LH 
exocytosis from intact cells was unaffected by cAMP over a 
similar concentration range (Table 9). cAMP stimulated LH 
exocytosis within 5 min and stimulation was sustained for at 
least 30 min (Figure 12). This differs from ca2+-stimulated 
LH exocytosis which is transient with no further exocytosis 
evident after 12-15 min (Figure 5). 
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The presence of the cyclic nucleotide phosphodiesterase 
inhibitor IBMX (0.25 mM) decreased the EC50 of cAMP from 30 
µM to 10 µM (Figure 11). When used alone, or in combination 
with IBMX, cGMP (300 µM) did not stimulate LH exocytosis 
(Table 10). This result suggests that cGMP does not have a 
role in mediating acute GnRH-stimulated LH exocytosis, a 
finding which differs from an earlier study in intact cells 
(Snyder et al., 1978). It also indicates that IBMX enhances 
cAMP-stimulated LH exocytosis by inhibiting cAMP hydrolysis 
rather than cGMP hydrolysis. All subsequent experiments with 
cAMP were conducted in the presence of 0.25 mM IBMX, a 
concentration which caused optimal enhancement of cAMP-
stimulated LH exocytosis without increasing basal LH release 
(Figure 13). Neither cAMP nor IBMX affected a-toxin 
permeabilization as measured by leakage of phosphorylated 2-
deoxy[3H]glucose metabolites (Table 6). 
TABLE 10 THE EFFECTS OF cGMP ON LH EXOCYTOSIS 
Permeabilized cells were equilibrated at 0°C for 30 minutes 
with stimulation buffer containing 10 mM CaEGTA (pea 7) and 
the indicated additions. Exocytosis was initiated by 
replacing with identical buffer at 37°C and LH release after 
10 minutes was determined. 
Addition % LH releasea 
control 2.50 ± 0. 11 
cGMP 300µM 2.90 ± 0.10* 
IBMX 0.25mM 2.78 ± 0.32* 
cGMP 300µM + IBMX 0.25mM 2.96 ± 0.33* 
CAMP 300µM + IBMX 0.25mM 7.04 ± 0.22** 
aMean and SEM of triplicate determinations. 
*not significantly different from control 
**significantly different from control (p < 0,001) 
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cAMP caused a modest increase in the the sensitivity of LH 
exocytosis to ca2+, shifting the EC50 for ca2+ from pCa 5.6 
to pCa 5.9, but had little effect at high [ca2+]free (Figure 
14). To investigate the effect of cAMP at very low 
[Ca2+Jfree, pH 7.1 (rather than 6.6) was used, for the same 
reasons explained in Section 3.2.3. Although cAMP-stimulated 
LH exocytosis was much reduced at low [ca2+]free, some 
stimulation was still evident at [ca2+]free as low as pCa 9 
(Figure 14, inset; Table 11). 
TABLE 11 CAMP-STIMULATED LH EXOCYTOSIS AT LOW [ca2+]free 
The combined results of several independent experiments 
similar to Figure 14 are shown. 
LH released (%)a 
(a) pCa 9 (n = 3) 
Control 3.0 ± 0.4 
cAMP 100 µM + IBMX 0.25 mM 4.2 ± 0.4b 
( b) pCa 8 (n = 5) 
Control 2.3 ± 0.3 
cAMP 100 µM + IBMX 0.25 mM 3.9 ± 0.4b 
aMean ± SEM. 
bsignificantly different from the control (p < 0.05) 
PMA (100 nM) synergistically enhanced cAMP-stimulated LH 
exocytosis by both decreasing the EC50 for cAMP from 10 µM 
to 3 µM (Figures 11 and 15) and increasing the maximum LH 
response 5-7 fold (Figures 15 and 16). This synergistic 
interaction was present at low concentrations of PMA (1-3 
nM) which did not stimulate LH exocytosis in the absence of 
cAMP (Figure 16). Synergism between cAMP and PMA was 
decreased at low [ca2+]free (pea 8) but was fully expressed 
at resting [ca2+]free (pCa 7) and was not further enhanced 
at higher [ca2+]free (Figure 17). 
To further examine whether cAMP may mediate the effects of 
GnRH on LH exocytosis, the ability of GnRH to stimulate cAMP 
generation in intact cells was examined~ In the presence of 
IBMX, GnRH stimulated LH release from intact cells with EC50 
= 10-9 M (Figure 18). Under the same conditions, cellular 
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cAMP content was increased by GnRH with EC50 = 3 x 10-8 M 
(Figure 18). 
3.2.5 ATP Requirements for LH Exocytosis 
All the preceding experiments were conducted in the presence 
of 5 mM MgATP. Prolonged equilibration of permeabilized 
cells at 0°C in the absence of MgATP resulted in a gradual 
decrease in LH exocytosis when cells were subsequently 
stimulated with ca2+ (pea 5) at 37°c (Figure 19). The half-
time of this decrease (10-15 min) was similar to the half-
time of efflux of [14c]adenosine label (8-10 min; Figure 
19). Inclusion of 5 mM MgATP entirely prevented this 
decrease (Figure 19). When MgATP (final concentration 5mM) 
was added to permeabilized cells equilibrated for 70-90 
minutes in the absence of MgATP, ca2+-stimulated LH 
exocytosis was restored (Figure 20). Full restoration of 
ca2+-stimulated LH exocytosis required addition of MgATP 10 
minutes before exocytosis was initiated (Figure 20), the 
time lag presumably reflecting equilibration of 
extracellular MgATP with the cytosol. In addition to 
estabilishing the MgATP dependence of ca2+-stimulated LH 
exocytosis, these results demonstrate that a-toxin pores 
remain patent for at least 90 minutes at 0°C despite the 
absence of a-toxin in the medium. The continued ability of 
a-toxin-permeabilized cells to undergo undiminished ca2+_ 
stimulated exocytosis after more than 1 hour of 
equilibration at 0°C demonstrates the stability of the 
exocytotic mechanism in a-toxin permeabilized cells and 
argues against a requirement for any small molecule other 
than ATP for stimulated LH exocytosis. 
To further characterize the role of MgATP the concentration 
dependence of MgATP-supported ca2+-stimulated exocytosis was 
examined. Half-maximal support of LH exocytosis occurred at 
1.5 mM MgATP (Figure 21A). Of several nucleotide 
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triphosphates tested only UTP and ATPyS caused significant 
enhancement of ca2+-stimulated exocytosis in MgATP-depleted 
cells but both were less effective than ATP at the same 
concentration (Figure 22). High performance liquid 
chromatography analysis of these nucleotides performed by 
Dr. Peter Cole (Dept. Chemical Pathology, University of Cape 
Town) indicated that these compounds were not detectably 
contaminated with ATP (less than 2% contamination). It is 
notable that ATPyS stimulated LH exocytosis at pCa 7 (Figure 
22), an effect which may result from the formation of GTPyS 
from ATPyS, catalyzed by the action of nucleoside 
diphosphate kinases act~ng on endogenous GDP (see Section 
5 ) • 
Like ca2+-stimulated LH exocytosis, both PMA- and cAMP-
stimulated exocytosis were also dependent on millimolar 
MgATP concentrations (Figures 21B and 23). Half-maximal 
support of cAMP- and PMA-stimulated LH exocytosis occurred 
at about 3 mM and 2.5 mM MgATP respectively (Figures 21B and 
23). 
3.3 DISCUSSION 
3.3.1 a-Toxin permeabilized cells as a model for regulated 
exocytosis 
Several lines of evidence suggest that stimulated LH release 
from a-toxin permeabilized pituitary cells occurs by 
exocytosis. (1) LH release is stimulated by micromolar 
[Ca2+]free and is dependent on millimolar MgATP 
concentrations. These are properties typical of regulated 
exocytosis in other permeabilized cell systems (Knight and 
Baker, 1982; Knight et al., 1984; Ronning and Martin, 
1986a). (2) ca2+-stimulated LH release from permeabilised 
cells does not occur at 0°C, consistent with exocytosis 
rather than leakage of LH from damaged cells. Efflux of 2-
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deoxy[3H]glucose metabolites was only slightly decreased at 
0°C, indicating that inhibition of LH release at 0°C was not 
due to closure of a-toxin pores. (3) Whereas a-toxin causes 
efflux from cells of small molecules such as 2-
deoxy[3H]glucose-, [3H]uridine- and [12c]adenosine-labelled 
metabolites, large molecules such as LDH (Mr 134 000) do not 
leak out. It is unlikely, therefore, that LR-containing 
secretory vesicles, which are much larger than LDH, could 
leak out. (4) And finally, since a-toxin pores are are too 
small to transmit the a-toxin monomer (Mr 34 000), a direct 
effect of a-toxin on secretory vesicles is unlikely to 
occur. 
Although staphylococcal a-toxin has advantages over more 
widely used permeabilization tools such as digitonin or high 
voltage electric fields (see Section 1.2.3), the small size 
of the pores has the disadvantage that exchange of permeant 
molecules is slow (t1/2 8-10 min). To compensate for this an 
equilibration step at 0°C was introduced, during which 
exchange of small molecules through the pores continues 
while exocytosis is prevented. Slow exchange through the 
pores probably also explains the requirement for strong ca2+ 
buffering (see below). 
3.3.2 ca2+ dependence of LH exocytosis 
The ca2+ dependence of LH exocytosis from a-toxin 
permeabilized sheep gonadotropes (half-maximal stimulation 
at 2-3 µM [ca2+]free> is similar to that found for 
exocytosis in cells permeabilized using other techniques 
(Knight and Scrutton, 1986; Peppers and Holz, 1986; Howell 
and Gomperts, 1987; Luini and De Matteis, 1988). In 
contrast, the ca2+ requirements of exocytosis in a-toxin-
permeabilized adrenal chromaffin (Bader et al.,1986) and 
PC12 (Ahnert-Hilger et al., 1987) cells were reported to be 
much higher, with half-maximal secretion requiring 
[ca2+]free greater than 10 µM. An explanation for these 
discrepant results is suggested by the finding that high 
CaEGTA buffer concentrations are required to overcome 
cellular ca2+ sequestration in a-toxin permeabilized 
gonadotropes. Indeed, at low CaEGTA buffer concentrations (5 
mM), half-maximal LH exocytosis occurred at apparent 
[ca2+]free greater than 10 µM. Grant et al. (1987) have 
compared the ca2+ sensitivity of exocytosis in digitonin-
permeabilized- and a-toxin-permeabilized adrenal chromaffin 
cells using identical ca2+ buffering systems. They found 
that half-maximal exocytosis occurred at 3 and 30 µM 
[ca2+]free in digitonin-permeabilized- and a-toxin-
permeabilized adrenal chromaffin cells, respectively. Taken 
together with results in this study, these findings suggest 
that more effective ca2+ buffering is required to clamp 
cytosolic [ca2+]free in a-toxin permeabilized cells than in 
cells permeabilized using detergents or electric fields. 
This may be a consequence of a small pore size, resulting in 
a relatively slower equilibration of CaEGTA in a-toxin 
permeabilized cells, and allowing more time for cellular 
ca2+ sequestration. 
Shangold et al. (1988) have demonstrated, using fura-2 in 
single rat gonadotropes, that GnRH can stimulate oscillatory 
increases in cytosolic [ca2+]free which occasionally reach 1 
µM. The findings of the present study suggests that even 
this level is too low to stimulate significant LH 
exocytosis. However, since this value represents the average 
cytosolic [ca2+]free over a whole cell, it underestimates 
the large subcellular variations in [ca2+]free which are 
known to occur in many cells, including gonadotropes, upon 
' 
stimulation (Leong, 1989; Tank et al., 1988; Cheek et al., 
1989; Foskett et al., 1989; Kim and Westhead, 1989; Silver 
et al., 1990). This variation probably results from the 
localized mobilization of intracellular (Cheek et al., 1989) 
and extracellular (Silver et al., 1990) ca2+ combined with 
efficient buffering of increases in cytosolic [ca2+]free 
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(Rose and Loewenstein, 1975). It is therefore possible that, 
when intact cells are stimulated, [ea2+]free of 1 to 10 µM 
are reached in a localized region at the exocytotic site as 
a result of activation of plasma membrane ea2+ channels and 
mobilization of intracellular ea2+ stores close to the 
plasma membrane. The observation that, in the GH3B5 
pituitary cell line, thyrotropin releasing hormone 
stimulates oscillatory increases in cytosolic free ea2+ 
which reach 10 µM, indicates that very high [ea2+]free are 
attainable in response to physiological stimuli (Winiger and 
Schlegel, 1988). 
The time course of ea2+-stimulated LH exocytosis in 
' permeabilized cells is similar to GnRH-stimulated LH 
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exocytosis in intact cells with an initial spike phase of 
rapid exocytosis followed by a plateau phase of slow 
exocytosis (Davidson at al., 1988; Tasaka et al., 1988). 
This finding suggests that the biphasic pattern of GnRH-
stimulated LH exocytosis in intact cells is not merely a 
consequence of the biphasic changes in cytosolic free ea2+ 
concentration (Limor et al., 1987; Tasaka et al., 1988) but 
also reflects a change in the response of the exocytotic 
mechanism to a raised constant [ea2+]free· The finding of 
the present study that exocytosis terminates after 12 
minutes exposure to maximally effective [ea2+]free (pea 5), 
whereas it continues for longer at submaximal [ea2+]free 
(pea 5.5), suggests that LH exocytosis becomes refractory to 
high [ea2+]free· This could result either from 
desensitization to ea2+ at some step in the exocytotic 
mechanism, or from a depletion of ea2+-sensitive LH stores. 
3.3.3 PKC activation and LH exocytosis 
GnRH activates PKe and increases the cytosolic [ea2+]free 
(see Section 1.3.2), suggesting that these two simultaneous 
events may both be involved in GnRH-stimulated LH 
exocytosis. This possibility is supported by the finding in 
the present study that the PKC activator, PMA, stimulated LH 
exocytosis over a range of
0
ca2+ concentrations. PMA-
stimulated exocytosis required millimolar MgATP 
concentrations, which rules out the possibility that PMA-
stimulated LH exocytosis at low [ca2+]free results from the 
action of PMA on a residual population of intact cells 
since, in that case, PMA-stimulated exocytosis would not be 
MgATP dependent. The observation that, like ca2+, PMA 
stimulates biphasic LH exocytosis with an early spike phase 
followed by a late plateau phase suggests that PKC-
activation may be involved in both the spike and plateau 
phases of GnRH-stimulated LH exocytosis in intact cells. The 
ability of PMA to stimulate LH exocytosis at very low 
[ca2+]free suggests that exocytosis is regulated by an 
isoenzyme of PKC which has a very low ca2+ requirement. In 
this context it is of interest that the predominant PKC 
subtype found in the pituitary is the type II (or type B) 
isozyme (Yoshida et al., 1988) which retains considerable 
activity in vitro at very low [ca2+]free (Nishizuka, 1988). 
3.3.4 CAMP-stimulated LH exocytosis 
Since cAMP is known to increase the cytosolic [ca2+]free in 
a variety of cell types (see Section 3.1), the ability of 
cAMP analogues or forskolin to stimulate LH exocytosis in 
intact cells may be a consequence of increased [ca2+]free· 
In the present experiments, cytosolic [ca2+]free is strongly 
buffered with high concentrations of EGTA. The results 
establish conclusively that cAMP can stimulate LH exocytosis 
directly without any change in the [ca2+]free· The rapid 
effect of cAMP (evident at 5 min) indicates that cAMP could 
play a role in acute GnRH-stimulated LH exocytosis during 
which stores of previously-synthesized LH are released. 
Previous studies using intact rat pituitary cells have 
demonstrated stimulatory effects of cAMP analogues or 
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forskolin on LH secretion but stimulation was generally 
observed only after 1 to 4 hours (Makino, 1973; Naor et al., 
1975; Cronin et al., 1984; Bourne and Baldwin, 1987). The 
effect of cAMP analogues may be delayed because of their 
slow entry into the cell or because, in the rat, the effects 
of cAMP are mediated by an increase in LH synthesis (Bourne 
and Baldwin, 1987). 
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The ability of raised [ca2+]free to stimulate an increase in 
cytosolic cAMP concentrations by activating ca2+/calmodulin 
dependent adenylate cyclases (Brostrom et at., 1982; 
Minocherhomjee et al., 1988) raises the possibility that 
~a2+ stimulates LH exocytosis indirectly through effects on 
cAMP. This is clearly not the case since high [ca2+]free 
stimulated much more extensive LH exocytosis than maximally-
effective cAMP concentrations and ca2+ and cAMP, when used 
together, showed a synergistic interaction in stimulating LH 
exocytosis. 
When used alone, high concentrations of cAMP were necessary 
to stimulate exocytosis (EC50 30 µMin the absence of IBMX) 
and the maximal effect was small when compared to 
stimulation with ca2+ or phorbol ester. These findings 
might cast doubt on the physiological relevance of cAMP as a 
mediator of exocytosis. However, in the presence of the 
phorbol ester PMA, cAMP stimulated extensive LH exocytosis 
at low micromolar concentrations, well within the range of 
cAMP concentrations expected in vivo. Since GnRH stimulation 
results in an increase in cytosolic [ca2+]free and 
activates PKC (see Section 1.3.2), even a small increase in 
the cytosolic cAMP concentration would result in significant 
enhancement of LH exocytosis. Because PMA has previously 
been shown to be cabable of stimulating adenylate cyclase 
activity (Brostrom et al., 1982; Summers and Cronin, 1986) 
it could be argued that the effects of phorbol ester result 
from an increase in cAMP production. However, our finding 
that very low concentrations of cAMP dramatically enhance 
PMA-stimulated LH exocytosis suggest that cAMP does not 
mediate the effect of PMA. 
The stimulation of cAMP production by GnRH in intact 
gonadotropes supports a role for cAMP in GnRH-stimulated LH 
exocytosis. The different dose-dependence of GnRH-stimulated 
LH exocytosis and GnRH-stimulated cAMP production (EC50 10-9 
Mand 3x10-8 M respectively) is not unexpected since 
theoretical modelling of second messenger cascades predicts 
a shift in agonist dose-dependence to lower agonist 
concentrations when responses further down the cascade are 
examined (Strickland and Loeb, 1981). 
In conclusion, these results demonstrate that cAMP is able 
to directly stimulate LH exocytosis independently of its 
ability to cause changes in the [ca2+]free and that cAMP 
synergistically enhances PMA- and ca2+-stimulated LH 
exocytosis. These findings suggest that cAMP plays a major 
role in GnRH-stimulated LH exocytosis, through its 
synergistic interactions with PKC and ca2+. 
3.3.5 ATP requirements for LH exocytosis 
The results presented in Section 3.2.5 show that ca2+_, 
PMA-, and cAMP-stimulated LH exocytosis are absolutely 
dependent on the presence of millimolar concentrations of 
ATP. In studies on several other cell types, including the 
GH3 and AtT20 pituitary tumour cell lines, stimulated 
exocytosis was only partially decreased in the absence of 
ATP (Ronning and Martin, 1986a; Peppers and Holz, 1986; 
Luini and Matteis, 1988). Our finding that prolonged 
equilibration in the absence of ATP is required before 
complete loss of ca2+-stimulated LH exocytosis occurs 
suggests that ATP depletion may have been incomplete in 
these other studies. A recent study by Holz et al. (1989) 
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suggests that, in adrenal chromaffin cells, a 9omponent of 
ca2+-stimulated exocytosis can occur in the absence of ATP, 
provided that the cells are exposed to ATP before ca2+ 
stimulation. Since stimulated exocytosis was lost rapidly 
(within 8 min) in the absence of ATP, these results do not 
contradict the present findings, but suggest instead that 
·ATP may be required for a reversible priming reaction which 
occurs independently of ca2+. The ATP dependence that we 
observed may result from a reversal of this priming step. 
The results of the present study allow limited speculation 
concerning the precise nature of ATP-requiring step(s) 
involved in stimulated LH exocytosis. The finding that 
millimolar ATP concentrations are required for ca2+_, PMA- , 
and cAMP-stimulated LH exocytosis, while most protein 
kinases (Edelman et al., 1987), including PKC (Kishimoto et 
al., 1977; Wise et al., 1982) and PKA (Beebe and Corbin, 
1986), require only micromolar ATP concentrations (Km 
typically< 20 µM), suggests that there is an ATP - dependent 
step other than protein kinase activation involved in 
second-messenger-stimulated LH exocytosis. An alternative 
explanation is that the cytosolic ATP concentrations 
obtained using our experimental protocol are considerably 
(at least 100 fold) lower than the extracellular ATP 
concentrations. Failure of the added ATP to reach the 
cytosol seems unlikely in view of the permeability of the 
cells to radiolabelled nucleotides. Rapid breakdown of ATP 
is also unlikely because it would require the consumption o f 
more than 99% of the available cytosolic ATP within minutes 
of the initiation of LH exocytosis by warming to 37°C. 
Furthermore, if exocytosis required only micromolar 
concentrations of ATP then the time dependence of the loss 
of ca2+-stimulated LH exocytosis (Figure 19) would not be 
similar to the time- dependence of the efflux of 
[14c]adenosine-labelled metabolites. The lower relative 
effectiveness of the slowly-hydrolysing ATP analogue, ATPyS, 
in supporting ca2+-stimulated LH exocytosis suggests that 
ATP hydrolysis is involved. 
In conclusion, a model of regulated exocytosis using 
Staphylococcus aureus a-toxin as a permeabilizing agent in 
primary anterior pituitary cells has been developed and 
characterized. Using this model it was shown that ca2+, PMA, 
and cAMP are able to stimulate LH exocytosis and that 
regulated exocytosis is absolutely dependent on millimolar 
ATP concentrations. 
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4 DEFINING THE CALCIUM TARGET; CALCIUM STIMULATES LH 
EXOCYTOSIS BY A MECHANISM INDEPENDENT OF PKC OR CALMODULIN 
4.1 INTRODUCTION 
Although it has long been known that ca2+ is the dominant 
stimulus of regulated exocytosis in a variety of cells 
(Section 1 .1), including gonadotropes (Section 1.3), the 
exact mechanism by which ca2+ stimulates exocytosis is not 
known (see Section 1.1). One possibility is via activation 
of the ca2+-sensitive protein kinase, PKC (Baker and Knight, 
1986; Nishizuka, 1986). In view of the absence of specific 
inhibitors of PKC (Rando, 1988; Huang, 1989), studies on a 
putative role for PKC in ca2+-stimulated exoc,ytosis have 
relied on the down-regulation of PKC by prolonged incubation 
with phorbol esters (Phillips and Jaken, 1983; Rodriguez-
Pena and Rozengurt, 1984). ca2+-stimulated exocytosis was 
decreased following PKC down-regulation in adrenal 
chromaffin cells (Burgoyne et al., 1988) but not in PC12 
cells (Matthies et al., 1988) nor in pancreatic islets (Hii 
et al., 1987), suggesting heterogeneity in the mechanism of 
ca2+-stimulated exocytosis. However, experiments utilising 
PKC down-regulated cells have several drawbacks (see Section 
4.3) which makes their interpretation difficult. This is 
illustrated by the conflicting results obtained in two 
recent studies which used PKC down-regulated anterior 
pituitary cells to investigate the requirement for PKC in 
GnRH-stimulated LH exocytosis (McArdle et al., 1987; 
Stojilkovic et al., 1988b). 
A second possible target for ca2+ is the ubiquitous ca2+_ 
binding protein calmodulin (Conn et al., 1987). Calmodulin 
is present in the anterior pituitary and redistributes from 
the cytosol to the plasma membrane following GnRH 
stimulation (Conn et al., 1981a). Further evidence for a 
role for calmodulin is the finding that antipsychotic 
calmodulin inhibitors inhibit ca2+ ionophore-stimulated LH 
exocytosis in intact cells (Conn et al., 1981b; Davidson et 
al., 1987a). However, these hydrophobic calmodulin 
inhibitors lack specificity in that they have effects on 
surface membrane potential (McLaughlin and Whitaker, 1988), 
inhibit PKC (Sanchez et al., 1983), and bind to several non-
calmodulin proteins in a ca2+-dependent way (Moore and 
Dedman, 1982). 
In the present study several different approaches, in 
addition to PKC down-regulation, were used to provide 
evidence that ca2+ stimulates LH exocytosis by a mechanism 
independent of PKC activation. Furthermore, evidence is 
presented which argues against a role for calmodulin. 
4.2 RESULTS 
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When permeabilized gonadotropes which have been equilibrated 
at O °C with high [ca2+]free (pCa 5) are warmed to 37 °C 
there is burst of LH exocytosis (Figures 5, 24, and 28). LH 
release is maximal during the first 3-5 minutes and declines 
to near basal levels after 12-20 minutes despite the 
continued presence of high [ca2+]free· This refractoriness 
to ca2+ could be due either to a depletion of ca2+-sensitive 
LH stores, or to desensitization of the exocytotic apparatus 
to ca2+. Addition of the PKC-activating phorbol ester PMA to 
cells which had been made refractory to ca2+ resulted in 
further release of LH (Figure 24). The quantity of LH 
released from ca2+-refractory cells in response to PMA was 
comparable to that released from cells kept at low 
[ca2+]free (pea 8) (Figure 24) which suggests that the PMA-
sensitive LH stores are not markedly depleted by prolonged 
exposure to high [ca2+]free· This finding demonstrates that 
ca2+ and PMA stimulate LH exocytosis, at least in part, by 
different mechanisms. 
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Staurosporine, a potent, though non-specific, inhibitor of 
PKC (Tamaoki et al., 1986; Ruegg and Burgess, 1989), blocked 
PMA-stimulated LH exocytosis (IC50 10-20 nM) but had little 
effect on ca2+_stimulated LH exocytosis (Figure 25 and Table 
12). Staurosporine also blocked the enhancement by PMA of 
ca2+-stimulated exocytosis over a range of ca2+ 
concentrations, while having little effect on ca2+_ 
stimulated exocytosis itself (Figure 26). The effects of 
other PKC inhibitors were also examined (Table 13). 
Sphingosine (Hannun and Bell, 1989) was a poor inhibitor of 
PMA-stimulated LH exocytosis except at high concentrations 
at which basal LH release was elevated (Table 13), probably 
as a result of cell damage (Hannun and Bell, 1989). Unlike 
staurosporine, acridine orange (Hannun and Bell, 1988) 
inhibited both PMA- and ca2+-stimulated LH exocytosis. 
However inhibition was only observed at high concentrations, 
casting doubt on the specificity of this effect (Table 13). 
TABLE 12 INHIBITION OF PHORBOL ESTER-STIMULATED EXOCYTOSIS 
BY STAUROSPORINE 
The ability of staurosporine to inhibit LH exocytosis 
stimulated by 100 nM PMA (pea 8) was examined using the same 
protocol as in Figure 25. 
Experiment IC50 (nM) Maximal inhibition(%) 
1 . * 86 
2. 20 84 
3. 20 95 
4. * 95 
5 . * 81 
6. 10 72 
*Insufficient data for determination of IC50, 
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TABLE 13 EFFECTS OF ACRIDINE ORANGE AND SPHINGOSINE ON LH 
EXOCYTOSIS 
Permeabilized cells were equilibrated at 0°C for 30 min with 
stimulation buffer containing 30 mM CaEGTA (pCa 8 or 5) with 
the indicated additions. Exocytosis was initiated by 
replacing with identical medium at 37°C and LH exocytosis 
after 10 min was determined. 
LH released(%) with .. a 
Additions pea 8 pCa 8 + PMA 100 nM pCa 5 
------------------------------------------------------------
(a) Sphingosine (µM) 
0 2. 1 ± 0. 1 10.8 ± 0.9 n.d. b 
10 1 . 7 ± 0. 1 9.3 ± 0.7 n.d. 
30 1 . 9 ± 0.3 7.5 ± 0.2 n.d. 
100 5.7 ± 0.9 6.1 ± 0.1 n.d. 
( b) Acridine Orange (µM) 
0 1.8 ± 0.2 6.2 ± 0. 1 21 . 0 ± 0.2 
30 n.d. 6.8 ± 0. 1 22.4 ± 0.5 
100 n.d. 7.7 ± 0. 1 19.9 ± 0. 1 
300 n.d. 6.6 ± 0.5 16.3 ± 0.8 
1000 < 1 < 1 < 1 
aMean ± range of duplicate determinations. Similar results 
were obtained in two independent experiments. 
bNot done 
Cells i ncubated for prolonged periods with high 
concentrations of PMA become desensitized to PMA as a result 
of proteolytic degradation of cellular PKC (Phillips and 
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Jaken, 1983; Rodriguez-Pena and Rozengurt, 1984; Melloni et 
al., 1986; Young et al., 1987) . Sheep anterior pituitary 
cells exposed to a high concentration of PMA for 24 hours 
did not release LH in response to subsequent stimulation 
with PMA, indicating desensitization (Figure 27). ca2+ was 
still able to stimulate LH exocytosis in these PMA-
desensitized cells although the absolute amount of LH 
released was decreased (Figure 27A). This decrease may 
reflect, in part, a depletion of releasable LH since cells 
desensitized to PMA contained less cellular LH than 
untreated cells (Table 14). When LH release was normalized 
to a percentage of cellular LH present immediately before 
stimulation, ca2+-stimulated exocytosis was not inhibited in 
PMA-desensitized cells (Figure 27B). 
TABLE 14 EFFECT OF PMA-PRETREATMENT ON CELLULAR LH CONTENT 
The LH content of cells used in the experiment shown in 
Figure 27 is shown. 
Control cells (n = 16) 
PMA pretreated cells (n ~ 4) 
Cellular LH (ng/well)a 
760 ±· 10 
270 ± 20 
aMean ± SEM of n determinations (where . n = number of wells) 
Since Ba2+ is a poor activator of either PKC (Takai et al., 
1979; Sekiguchi et al., 1988) or calmodulin (Chao et al., 
1984; Kuret and Schulman, 1984) in vitro and yet is a 
powerful LH secretagogue in intact pituitary cells (Davidson 
et al., 1987b, Smith et al., 1989) we examined Ba2+_ 
stimulated LH exocytosis in permeabilized cells to determine 
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whether Ba2+ activates the same exocytotic mechanism as 
ca2+. High [Ba2+]free stimulated LH exocytosis in 
permeabilized gonadotropes with a time course very similar 
to ca2+-stimulated LH exocytosis (Figure 28A). As was the 
case with ca2+, cells eventually became refractory to high 
[Ba2+]free but could still release LH in response to PMA 
(Figure 28A). Ba2+ was not able to stimulate LH exocytosis 
in cells made refractory to ca2+ whereas Ba2+ could 
stimulate LH exocytosis when added to cells which had been 
maintained at low [ca2+]free (pCa 7) (Figure 28B). Ba2+-
stimulated LH exocytosis was half-maximal at pBa 3.6, a 
concentration 100 fold higher than for ca2+ (Figure 29). 
Concentrations of Ba2+ higher than pBa 3 inhibited LH 
exocytosis (Figure 29) in a manner similar to the inhibition 
of LH exocytosis by very high ca2+ concentrations (Figure 
6). Maximally effective concentrations of [Ba2+]free (pBa 3) 
and [ca2+]free (pCa 5) stimulated LH exocytosis to a similar 
extent (Table 15). Ba2+-stimulated LH exocytosis, like ca2+_ 
stimulated LH exocytosis, was not inhibited by staurosporine 
(Figure 25). Taken together, these findings suggest that 
Ba2+ and ca2+ stimulate exocytosis by the same mechanism. 
Since Ba2+ does not activate PKC or calmodulin these 
findings provide further evidence against a major role for 
PKC in ca2+-stimulated LH exocytosis, and also suggest that 
calmodulin does not mediate the the effects of ca2+. 
TABLE 15 COMPARISON OF MAXIMAL ca2+_ AND Ba2+_sTIMULATED LH 
EXOCYTOSIS 
Results are shown of several experiments similar to Figure 
28 in which ca2+ and Ba2+ where used at maximally effective 
concentrations (pCa 5 and pBa 3, respectively) within the 
same experiment. LH exocytosis was measured over 10 min. 
LH exocytosis (%) 
Experiment 
pBa 3 pea 5 
1 . 14. 9 15.6 
2. 16.4 16. 8 
3. 15.8 14. 9 
4. 13.4 10.4 
5. 11 . 4 9.0 
6. 10.2 15. 7 
Mean± SEM 13.7 ± 1 13.7 ± 1.3 
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The role of calmodulin was examined further using calmodulin 
inhibitors. The antipsychotic calmodulin inhibitor 
trifluoperazine inhibited PMA-, as well as ca2+_ and Ba2+_ 
stimulated LH exocytosis at similar doses (Figure 30), 
confirming doubts about its specificity (see Section 4.1). 
In contrast, the more potent and specific calmodulin 
inhibitor calmidazolium (Gietzen et al., 1981) inhibited 
neither PMA- nor ca2+-stimulated LH exocytosis at 
concentrations up to 30 µM (Figure 31). Higher 
concentrations of the drug caused an increase in basal LH 
release, probably as a result of cell damage (Figure 31). 
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4.3 DISCUSSION 
McArdle et al. (1987) examined the role of PKC in ca2+-
stimulated LH exocytosis in intact cells and found that PKC 
down-regulation did not inhibit calcium ionophore (A23187)-
stimulated LH exocytosis. However, PKC can modulate the 
·activity of several important ca2+-regulating proteins 
including plasma membrane ca2+ channels (Yamaguchi et al., 
1987; Yada et al., 1989), plasma membrane ca2+_ATPases 
(Nishizuka, 1986; Smallwood et al., 1988), and ca2+_ATPases 
associated with intracellular ca2+ stores (Yoshida and 
Nachmias, 1989; Rogers et al., 1990) and this may affect the 
extent of ionophore-induced increases in cytosolic 
[ca2+]free· Furthermore, experiments involving PKC down-
regulation are difficult to interpret for reasons outlined 
below. Therefore several different approaches, in addition 
to PKC down-regulation, were used in the present study to 
investigate the possible role of PKC and these experiments 
were conducted in permeabilized cells, which allow direct 
control of the cytosolic [Ca2+]free· 
From the results presented above, several lines of evidence 
suggest that ca2+-stimulated LH exocytosis is not mediated 
by PKC. 
(1) The PKC activator PMA enhances LH exocytosis at all ca2+ 
concentrations (Figures 9, 26, and 27). If ca2+ were acting 
via PKC, LH exocytosis at maximal [ca2+]free should not be 
further enhanced by PMA since PMA does not enhance maximal 
ca2+_stimulated PKC activity in vitro (Sekiguchi et al., 
1988). The effects of PMA and ca2+ on LH exocytosis are 
additive which suggests that PMA-stimulated LH exocytosis is 
largely ca2+_independent. In this context it of interest 
that the major rat pituitary PKC isoenzyme (type II or B) 
(Yoshida et al., 1988) shows only slight ca2+_dependence 
when compared with the type I(y) and III(a) isoenzymes 
(Sekiguchi et al. 1988). 
(2) PMA was able to stimulate LH exocytosis in cells made 
refractory to high [ca2+]free· Two possible explanations for 
this finding are: (a) that there exists a pool of releasable 
LH which is sensitive to PMA but not ca2+; or (b) that PMA 
and ca2+ stimulate LH release from the same store but that 
the ca2+ mechanism desensitizes before depletion of 
releasable LH occurs. Although our results cannot 
distinguish between these two possibilities, both these 
explanations imply that ca2+ is not acting through PKC. 
81 
(3) The PKC inhibitor, staurosporine, had little effect on 
ca2+-stimulated LH exocytosis though it blocked PMA-
stimulated LH exocytosis. The fact that staurosporine is a 
non-specific PKC inhibitor (Ruegg and Burgess, 1989) in that 
it also inhibits protein kinase A (Tamaoki et al., 1986) and 
myosin light chain kinase (Watson et al., 1988) does not 
alter this conclusion. The absence of an inhibitory effect 
of stuarosporine is strong evidence that ca2+-stimulated LH 
exocytosis is not mediated by PKC. 
(4) ca2+ stimulates LH exocytosis in cells completely 
desensitized to PMA. Although not demonstrated directly 
here, it is likely that this desensitization results from 
depletion of PKC (Phillips and Jaken, 1983; Rodriguez-Pena 
and Rozengurt, 1984; McArdle et al., 1987; Stojilkovic et 
al., 1988b). Experiments of this type in which PKC is 
depleted by prolonged phorbol ester stimulation are 
difficult to interpret for the following reasons: (a) 
Prolonged activation of PKC by phorbol ester is likely to 
result in pleiotropic cellular changes due to 
phosphorylation of multiple proteins (Nishizuka, 1986). Thus 
observed changes may be due to mechanisms other than down-
regulation of PKC. (b) Prolonged exposure to phorbol ester 
results in depletion of LH stores (McArdle et al., 1987; 
Stojilkovic et al., 1988b; and this study) and this is 
likely to reduce the amount of releasable LH. In the present 
study in which acute LH exocytosis (over 10 min) was studied 
LH depletion was corrected for by expressing LH exocytosis 
as a percentage of the available cellular LH at the 
beginning of the experiment. However, when LH exocytosis is 
measured over several hours, as in previous studies (McArdle 
et al., 1987; Stojilkovic et al., 1988b), substantial LH 
synthesis takes place during the course of the experiment 
(Stojilkovic et al., 1988b) and it is therefore not clear 
how one should calculate the percentage of LH released. 
Finally, (c) the rate of PKC down-regulation varies between 
cell types (Adams and Gullick, 1989) and between ·different 
isoenzymes of PKC (Huang et al., 1989; Kishimoto et al., 
1989; Isakof et al., 1990). Together these considerations 
suggest that experiments conducted on PKC down-regulated 
cells should be interpreted with caution and should not be 
used as the only evidence for or against a role for PKC in 
cellular processes. 
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(5) Ba2+ was able to stimulate LH exocytosis even though 
Ba2+ is a poor activator of PKC in vitro and in fact 
inhibits the type II or B isoenzyme (Takai et al., 1979; 
Sekiguchi et al., 1988) which is the major isoenzyme present 
in the rat pituitary (Yoshida et al., 1988). This is in 
agreement with studies on catecholamine exocytosis using PC-
12 cells (Mattheis et al., 1988). Our finding that PMA is 
able to stimulate LH exocytosis from cells refractory to 
Ba2+ also indicates that Ba2+ does not stimulate exocytosis 
by activating PKC. The following findings suggest that Ba2+ 
and ca2+ stimulate LH exocytosis by the same mechanism: (a) 
Ba2+ and ca2+ stimulated LH exocytosis with the same time 
course; (b) maximal Ba2+_ and ca2+-stimulated LH exocytosis 
were the same; (c) Ba2+ was unable to stimulate LH 
exocytosis from cells made refractory to ca2+; (d) high 
concentrations of both Ba2+ and ca2+ inhibited LH 
exocytosis; and (e) neither Ba2+_ nor ca2+-stimulated LH 
exocytosis was inhibited by staurosporine. 
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While the evidence presented above argues strongly against a 
role for PKC as the mediator of ca2+-stimulated LH 
exocytosis, this does not necessarily imply that ca2+ and 
PMA stimulate exocytosis by completely separate and parallel 
pathways. The data is compatible with ca2+ and PMA 
activating a final common exocytotic pathway distal to PKC 
and the ca2+ target. 
In contrast to the present study, studies bovine adrenal 
chromaffin cells permeabilized by digitonin or high-voltage 
electric field have been interpreted to implicate PKC as a 
target for ca2+ in regulated exocytosis (Burgoyne et al., 
1988; Knight et al. 1988). Burgoyne et al. (1988) 
demonstrated partial inhibition of ca2+-stimulated 
exocytosis in PKC down-regulated cells and concluded that 
PKC has a major role in ca2+-stimulated exocytosis. However, 
the inhibitory effect observed may have resulted from 
phorbol ester effects other than PKC depletion. 
Alternatively, PKC may play a modulatory role in 
catecholamine exocytosis without being the major ca2+ 
target. Knight et al. (1988) tested a range of PKC 
inhibitors (but not staurosporine) and fond none that did 
not also inhibit ca2+-stimulated exocytosis. However, their 
results may simply r~flect a lack of specificity of the 
agents used, as is the case many protein kinase C inhibitors 
(Rando, 1988; Huang, 1989) such as TFP and acridine orange 
as demonstrated in the present study (Figure 30 and Table 
13). Knight et al. (1988) also found that exocytosis and PKC 
(purified from bovine adrenal medulla) had similar cation 
and nucleotide specificities. While these data are 
consistent with a role for PKC in exocytosis they do not 
constitute proof of one. 
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The finding of the present study that Ba2+ can stimulate LH 
exocytosis, and that it acts by the same mechanism as ca2+, 
argues strongly against a role for calmodulin in ca2+_ 
stimulated LH exocytosis, since Ba2+ does not bind to 
calmodulin or activate calmodulin dependent enzymes even at 
concentrations as high as 1 mM (Chao et al., 1984; Kuret and 
Schulman, 1984). Further evidence against a role for 
calmodulin is the finding that calmidazolium, a much more 
potent and specific calmodulin inhibitor than 
trifluoperazine (Gietzen et al., 1981), does not inhibit 
ca2+-stimulated LH exocytosis. 
The results of the present study indicate that PKC is not a 
mediator of ca2+-stimulated LH exocytosis, but they do not 
exclude a role for PKC in GnRH-induced LH exocytosis. Other 
studies from this laboratory (not shown in this thesis) 
demonstrated that, in intact cells, the PKC-inhibitor 
staurosporine enhanced GnRH-stimulated LH exocytosis under 
conditions where it inhibited PMA-stimulated exocytosis (van 
der Merwe et al., 1990). This argues against a role for PKC 
in GnRH stimulus-secretion coupling. Although the precise 
role of PKC is not known, there is some evidence that it 
mediates (a) GnRH stimulation of LHB-subunit gene 
transcription (Andrews at al., 1988) and (b) feedback 
effects of GnRH-stimulation on the GnRH receptor (Huckle et 
al., 1988; Huckle et al., 1989). 
In conclusion, these results indicate that ca2+ stimulates 
LH exocytosis by a mechanism which does not involve PKC or 
calmodulin. Although the data do not suggest what the ca2+ 
target is, there are a large number of ca2+-sensitive 
proteins which have already been identified which may 
mediate ca2+-stimulated exocytosis (see Section 1.1). 
5 DUAL STIMULATORY AND INHIBITORY EFFECTS OF GUANINE 
NUCLEOTIDES ON LH EXOCYTOSIS 
5.1 INTRODUCTION 
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GTP-binding proteins play diverse roles in several cellular 
processes including protein synthesis, microtubule assembly, 
intracellular vesicle trafficking, targeting of secretory 
proteins to the endoplasmic reticulum, and stimulus-
secretion coupling (Gilman, 1987; Allende, 1988; Balch, 
1989; Rothman, 1989). A family of heterotrimeric GTP-binding 
proteins (G-proteins) couple certain cell surface receptors 
to plasma membrane ion channels (Houslay, 1987; Rosenthal et 
al., 1988) and intracellular effectors such as adenylate 
cyclase, phospholipase A2, phospholipase D, 
phosphatidylinositol-specific phospholipase C 
(phosphoinositidase C, PIC), and phosphatidylcholine-
specific phospholipase C (Gilman, 1987; Fain et al., 1988; 
Martin and Michaelis, 1989; Pelech and Vance, 1989). In 
addition, there is a family of small (Mr 20 000 - 27 000) 
proteins which includes the ras proto-oncogenes which can be 
detected by their ability to bind GTP after separation on 
SDS-PAGE (Burgoyne, 1989). The functions of this group of 
GTP-binding proteins are not clear. 
Recently, two lines of evidence have accumulated supporting 
the involvement of GTP-binding proteins in exocytosis. 
Firstly, studies on a temperature-dependent yeast mutant 
with a defect in constitutive exocytosis have identified the 
gene product SEC4 as a 23.5 kDa ras-like GTP-binding protein 
which associates with yeast secretory vesicles (Salminen and 
Novick, 1987; Goud et al., 1988). Secondly, intracellular 
application of GTP analogues has been reported to modulate 
exocytosis in several cell types. GTP analogues stimulate 
exocytosis in mast cells (Gomperts, 1983; Howell et al., 
1987), platelets (Haslam and Davidson, 1984), adrenal 
chromaffin cells (Knight and Baker, 1985; Bittner et al., 
1986), neutrophils (Barrowman et al., 1986), parathyroid 
cells (Oetting et al., 1986), RINm5F cells (Vallar et al., 
1987), gonadotropes (Andrews et al., 1986) and lactotropes 
(Sikdar et al., 1989). In some of these studies the GDP 
analogue GDPBS inhibited second-messenger-stimulated 
exocytosis (Barrowman et at., 1986; Bittner et al., 1986; 
Vallar et al., 1987). In contrast, GTP analogues have also 
been reported to inhibit exocytosis in bovine adrenal 
chromaffin cells (Knight and Baker, 1985), PC12 cells 
(Anhert-Hilger et al., 1987), and AtT20 cells (Luini and De 
Matteis, 1988 & 1990). 
In the present study guanine nucleotides were used to 
examine whether GTP-binding proteins have a role in 
regulating LH exocytosis. 
5.2 RESULTS 
5.2.1 Stimulatory effects of GTPyS and GMPPNP on LH 
exocytosis 
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In permeabilized cells buffered at resting cytosolic 
[ca2+]free (pea 7), GTPyS and GMPPNP stimulated rapid LH 
exocytosis. LH release was maximal between 5 and 10 min and 
declined to basal levels after 20 min (Figure 32A). Although 
GTPyS and GMPPNP stimulated LH exocytosis with similar 
potency (EC50 20-50 µM, n = 5 independent experiments) the 
maximal effect of GMPPNP was consistently greater than that 
of GTPyS (Figure 32B) and also more sustained (Figure 32A). 
GTP had little stimulatory effect at concentrations up to 3 
mM (Figure 32B). GDPBS did not stimulate LH exocytosis and 
inhibited the stimulatory effect of GTPyS (Table 16). GTPyS-
stimulated LH exocytosis was ATP dependent (Figure 32B), as 
was the case for ca2+_, phorbol ester- and cAMP-stimulated 
LH exocytosis (see Section 3). The ca2+-dependence of 
GMPPNP-stimulated LH exocytosis was examined (Figure 33). 
GMPPNP stimulating LH exocytosis most effectively at pCa 6, 
but was effective at both very low (pea 9-8) and high 
[ca2+]free (pea 5-4.5) (Figure 33). 
TABLE 16 EFFECT OF GDP8S ON GTPyS-STIMULATED LH EXOCYTOSIS 
Permeabilized cells were equ~librated at 0°C for 30 min in 
stimulation buffer containing 30 mM CaEGTA (pea 6) and the 
indicated nucleotides. LH exocytosis was initiated by 
replacing with identical stimulation buffer at 37°C and LH 
released after 15 min was determined. 
Addition % LH Releaseda 
Control 6.5 ± 0.1 
GTPyS 300µM 28.6 ± 0.9 
GDPBS 2mM 4.4 ± 0.8 
GTPyS 300µM + GDPBS 2 mM 5.8 ± 0.5 
aMean ± range of duplicate determinations. Similar results 
were obtained in three independent experiments. 
Since both PKC activation and cAMP can stimulate LH 
exocytosis, a probable mechanism for the stimulatory effect 
of guanine nucleotides is through the activation of signal-
transducing G-proteins which would result in the generation 
of diacylglycerol (if a phospholipase C or phospholipase D 
were activated), or cAMP (if adenylate cyclase was 
activated). 
GMPPNP was able to stimulate a further increase in LH 
exocytosis in the presence of maximally effective 
concentrations of the PKC-activating phorbol ester PMA 
(Figure 34). GMPPNP was approximately additive with PKC at 
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all doses. To examine further whether activation of PKC 
mediates the effects of GMPPNP, cells were desensitized to 
PMA by prolonged treatment with high concentrations of 
phorbol ester (Table 17). Cells incubated overnight with PMA 
were unresponsive to subsequent acute stimulation with PMA, 
indicating PKC desensitization (Table 17). However, GMPPNP 
was still able to stimulate LH exocytosis in PKC depleted 
cells (Table 17). Taken together, these findings indicate 
that GMPPNP does not act solely by activation of PKC and 
suggest that other mechanisms are involved. 
GMPPNP was able to stimulate a further increase in LH 
exocytosis in the presence of maximally-effective 
concentrations of cAMP, although the effects of GMPPNP and 
cAMP were slightly less than additive (Figure 34). 
Therefore, the stimulatory effects of guanine nucleotides 
are not fully explained either by stimulation of cAMP 
generation alone or by the isolated activation of PKC. 
However, it is possible that simultaneous activation of both 
of these second messenger pathways could account for the 
guanine nucleotide effects. In support of this GMPPNP was 
unable to further stimulate LH exocytosis from cells 
stimulated with maximal concentrations of cAMP plus PMA 
(cAMP/PMA) (Table 17). 
TABLE 17 EFFECTS OF cAMP, PHORBOL ESTER, AND GMPPNP ON LH 
EXOCYTOSIS IN PHORBOL ESTER-DESENSITIZED CELLS 
Cells were pre-treated with vehicle [Me2SO 0.13%] or PMA 
(250 nM) for 18 h. They were then washed and permeabilized 
as usual and equilibrated at 0°C for 30 min in stimulation 
buffer with CaEGTA 30 mM (pea 7) and the indicated 
additions. LH exocytosis was initiated by replacing with 
identical stimulation buffer at 37°C and LH released after 
20 min was determined. LH release is expressed as a 
percentage of the cellular LH content immediately before 
stimulation which was: Me2SO pre-treated cells, 920 ± 40 
ng/well; PMA pre-treated cells, 340 ± 10 ng/well (mean± 
SEM, n = 4 wells). Similar results were obtained in three 
independent experiments. 
% LH Releaseda 
(a) no phorbol ester pre-treatment 
control 3.7 ± 0.1 
GMPPNP (500 µM) 11 . 0 ± 0.3 
PMA (250nM) 19.0 ± 0. 1 
PMA + GMPPNP 23.9 ± 1. 2 
PMA + CAMP (30µM) + IBMX (250µM) 29.3 ± 0.7 
PMA + CAMP+ IBMX + GMPPNP 29.2 ± 2.4 
( b) phorbol ester pre-treated 
control 7.5 ± 0.6 
GMPPNP (500 µM) 15.2 ± 0.6 
PMA (250nM) 8. 1 ± 0.4 
PMA + GMPPNP 13.3 ± 1 . 2 
PMA + CAMP ( 30µM) + IBMX (250µM) 19. 1 ± 1. 6 
PMA + cAMP + IBMX + GMPPNP 17.8 ± 0.9 
aMean ± range of duplicate determinations. 
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5.2.2 Inhibitory effects of GTPyS on LH exocytosis 
In contrast to the acute stimulatory effects of guanine 
nucleotides described above, GTPyS was found to inhibit LH 
exocytosis under certain conditions. In cells stimulated 
with cAMP/PMA, low concentrations of GTPyS (which were not 
stimulatory) inhibited LH exocytosis after a lag of 5 min 
(Figure 35). In subsequent experiments cells were pre-
incubated with guanine nucleotides for 30 min at 37°C in the 
absence of ATP (see Figure 36 for an outline of the 
protocol). The absence of ATP prevented guanine nucleotide 
stimulation of LH exocytosis during the pre-incubation 
(Figure 32B). After pre-incubation cells were stimulated in 
the presence of ATP but in the absence of guanine 
nucleotides. Since the inhibitory effect of GTPyS 
pretreatment did not require its continued presence during 
the stimulation period (Table 18), guanine nucleotides were 
omitted during the stimulation period. This was desirable in 
order to minimize their stimulatory effects. Using this 
protocol GTPyS inhibited ca2+-stimulated LH exocytosis (ICso 
10 µM), an effect not observed with GMPPNP or GTP at 
concentrations up to 100 µM (Figure 36). This inhibition by 
GTPyS does not result from depletion of releasable LH during 
the preincubation since GTPyS stimulated minimal LH 
exocytosis in the absence of ATP (Figure 32B). GTPyS 
inhibited cAMP-,PMA-, and cAMP/PMA-stimulated LH exocytosis 
even more potently (IC5os 1 µM) (Figure 37). The inhibitory 
effect of 30 µM GTPyS was prevented by including GMPPNP (0.1 
mM) and partly prevented by GDP (1 mM) and GTP (1 mM) 
(Figure 38) whereas ATP (6 mM) was without effect (Table 
19) • 
91 
TABLE 18 INHIBITORY EFFECT OF GTPyS PREINCUBATION ON LH 
EXOCYTOSIS 
Perrneabilized cells were equilibrated for 30 min at 0°C in 
buffer IC containing 2 rnM MgCl2 and 10 rnM CaEGTA (pea 7) 
with or without GTPyS (30 µM). Cells were then warmed to 
37°C and pre-incubated for 30 min in the same medium. This 
medium was removed and replaced with stimulation buffer 
containing 10 rnM CaEGTA (pCa 7) with or without cAMP (30 µM) 
plus IBMX (0.25 rnM) plus PMA (100 nM) (cAMP/PMA) and with or 
without GTPyS (30 µ). LH released after 30 min was 
determined. Results are expressed as the percent of 
cAMP/PMA-stirnulated LH release in the absence of GTPyS. 
Values for basal LH release (in the absence of cAMP/PMA) 
were subtracted. 
Pre-inc. Stirn. cAMP/PMA-stirnulated LH release (%)a 
Control Control 100 
Control GTPyS 40 ± 3 
GTPyS Control 30 ± 3 
GTPyS GTPyS 34 ± 1 
aMean ± range of duplicate determinations. Similar results 
were obtained in two independent experiments. 
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TABLE 19 THE EFFECT OF ATP ON GTPyS-INHIBITION OF LH 
EXOCYTOSIS 
Permeabilized cells were equilibrated for 30 min at 0°C in 
buffer IC with 2 mM MgCl2 and 10 mM CaEGTA (pCa 7) with 
indicated additions. Cells were then warmed to 37°C and pre-
incubated for 30 min in the same medium. This medium was 
removed and replaced with stimulation buffer containing 30 
mM CaEGTA (pea 5) and MgATP 5 mM (MgCl2 6.5 mM plus Na2ATP 6 
mM) and LH released after 30 min was determined. 
Pre incubation LH release (%)a 
MgCl2 2 mM 23.0 ± 1 
MgATP 5 mM 31 . 2 ± 4 
GTPyS 100 µM plus MgCl2 8.6 ± 0.2 
GTPyS plus MgATP 7.0 ± 0.1 
aMean and range of duplicate determinations. Similar results 
were obtained in two independent experiments. 
High concentrations of ATPyS also inhibited both ca2+_ 
stimulated (IC50 200 µM, Figure 39) and cAMP/PMA-stimulated 
LH exocytosis (IC50 20 µM, Figure 40). However, this 
inhibitory effect of ATPyS was antagonized by UDP (Figures 
39 and 40), a competitive inhibitor of nucleotide 
diphosphate kinase (Seifert et al., 1988), suggesting that 
ATPyS-inhibition results from nucleotide diphosphate kinase-
mediated synthesis of GTPyS. 
5.3 DISCUSSION 
These results demonstrate that intracellularly applied 
guanine nucleotides have both stimulatory and inhibitory 
effects on exocytosis in sheep gonadotropes. Several 
findings suggest that the stimulatory effects result from 
activation of one or more signal-transducing G-proteins with 
consequent generation of stimulatory second messengers. 
Firstly, in time course experiments, the stimulatory effects 
of GTPyS and GMPPNP were maximal between 5 and 10 min 
whereas the stimulatory effects of ca2+, PKC and cAMP are 
maximal in the first 5 min (see Section 3). The delay is 
compatible with guanine nucleotides having less direct 
mechanisms of action. Secondly, the combined stimulatory 
effects of GMPPNP and saturating cAMP concentrations were 
less than additive. And finally, in cells stimulated with 
saturating concentrations of PMA plus cAMP, GMPPNP was 
unable to stimulate further LH exocytosis. Although this 
latter finding suggests that the stimulatory effects of 
guanine nucleotides may mediated solely by PKC activation 
together with cAMP generation, it is possible that, when the 
cells were stimulated with cAMP/PMA, LH exocytosis had 
reached an inherent maximal rate, thus obscuring any 
additional GMPPNP effect. Our results do not, therefore, 
entirely exclude additional mechanisms for the stimulatory 
effect of guanine nucleotides. 
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Severa~ differences between the stimulatory effects and the 
inhibitory effects of guanine nucleotides indicate that they 
are exerted at different sites (Figure 41). Unlike the 
stimulatory effect, inhibition was observed only with GTPyS 
(not GMPPNP), it had a slower onset, and was produced by a 
10 fold lower concentration of GTPyS. The finding that GTPyS 
inhibits LH exocytosis stimulated by a variety of second 
messenger pathways (ca2+, PMA, and cAMP) indicates tat 
GTPyS inhibits exocytosis distal to the generation of second 
messengers. The delayed inhibitory effect of GTPyS, not 
found with GMPPNP, probably explains the lower maximal 
stimulation observed with GTPyS and shorter duration of 
GTPyS-stimulation when compared with GMPPNP (Figure 32A). 
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The finding that the inhibitory effect was observed with 
ATPyS as well as GTPyS but not GMPPNP raises the question 
whether the inhibition results from protein 
thiophosphorylation (Eckstein, 1985; Li et al., 1988). In 
support of this, GTP (and GTPyS) is preferred to ATP as the 
phosphate donor in some phosphorylation reactions (Amir-
Zaltsman et al., 1980; Amir-Zaltsman and Salomon, 1989) 
Since thiophosphorylated proteins are resistant to 
dephosphorylation (Li et al., 1988), processes requiring 
dephosphorylation, of which exocytosis may be one (Momayezi 
et al., 1987), will be inhibited. Our findings that (a) much 
higher concentrations of ATPyS than GTPyS are required for 
inhibition and (b) that the ATPyS effect is inhibited by a 
nucleotide-diphosphate kinase inhibitor (UDP) suggests that 
ATPyS-inhibition results from its intracellular conversion 
to GTPyS (Seifert et al., 1988). 
Intracellular application of guanine nucleotides can 
stimulate exocytosis in diverse cell types (see Section 
5.1). In several previous studies these results have been 
interpreted in terms of a stimulatory GTP-binding protein 
(GE) directly involved in exocytosis (Cockcroft et al., 
1987; Regazzi et at., 1989). In neutrophils (Barrowman et 
al., 1986), mast cells (Cockcroft et al., 1987), and RINm5F 
cells (Vallar et al., 1987; Regazzi et al., 1989) there is · 
evidence that the stimulatory effect of guanine nucleotides 
on exocytosis is not entirely due to the activation of PIC 
and/or adenylate cyclase. However, it remains possible that 
guanine nucleotides stimulate exocytosis through effects on 
other G-protein coupled effector systems such as 
phosphatidylcholine-specific phospholipase C, phospholipase 
A2, or phospholipase D (Burgoyne et al., 1987; Irving and 
Exton, 1987; Martin and Michaelis, 1989). 
In a few studies inhibitory effects of guanine nucleotides 
on second messenger-stimulated exocytosis have been 
demonstrated, and these provide more convincing evidence for 
the involvement of GTP-binding proteins other than signal-
transducing G-proteins in exocytosis. GTPyS has been 
reported to inhibit ca2+-stimulated exocytosis in bovine 
adrenal chromaffin cells (Knight and Baker, 1985) and PC12 
cells (Anhert-Hilger et al., 1987) over a concentration 
range similar to that found in the present study. 
Interestingly, GMPPNP was not inhibitory in bovine adrenal 
chromaffin cells (Knight and Baker, 1985), as we have found 
in gonadotropes. These similarities suggest that the 
mechanism of GTPyS inhibition may be common to many 
secretory cell types. 
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It is attractive to hypothesize that GTPyS inhibition is 
mediated by a GTP-binding protein directly involved in 
exocytosis. Recent studies have identified such a protein 
(SEC4) which is essential for constitutive exocytosis in 
yeast (Salminen and Novick, 1987; Goud et al., 1988). SEC4 
is a member of a large family of small (20-25 kDa), ras-like 
GTP-binding proteins some of which have been implicated in 
intracellular vesicle tafficking pathways in higher 
eukaryotes (Bourne, 1988; Balch, 1989; Burgoyne, 1-989). In 
support of this, GTPyS inhibits vesicle traf(icking in 
several mammalian cell free systems (Melan~on et al.,1987; 
Balch, 1989). Interestingly, and in agreement with our 
findings, GMPPNP is sometimes a considerably less potent 
inhibitor of vesicle trafficking than GTPyS (Melan~on et 
al., 1987). Furthermore, small GTP binding proteins have 
been found tightly bound to the cytosolic surface of bovine 
adrenal chromaffin (Burgoyne and Morgan, 1989) and sheep 
anterior pituitary* secretory granules. Based on these 
findings Bourne (1988) has proposed a model in which GTP-
*Unpublished work of J.S. Davidson and I.K. Wakefield in our 
laboratory. 
binding proteins may direct membrane traffic in the 
secretory pathway. He postulates, by analogy with the GTP-
binding proteins which participate in protein synthesis, 
that hydrolysis of GTP is an essential prerequisite for 
vesicle fusion and that it establishes unidirectional 
movement along the secretory pathway. Since this model 
predicts that non-hydrolysable GTP analogues will inhibit 
such a pathway, our results are compatible with such a 
mechanism. 
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An alternative mechanism has been proposed in which guanine 
nucleotides may inhibit exocytosis by activating GTP-binding 
proteins coupled to inhibitory receptors such as the 
somatostatin and 02-adrenergic receptors (Ullrich and 
Wollheim, 1988; Luini and De Matteis, 1990). However, this 
mechanism seems unlikely to apply to our results since no 
cell surface receptors on the gonadotrope are known to 
inhibit exocytosis. 
In conclusion, the findings of the present study indicate 
that guanine nucleotide-binding proteins are involved in LH 
exocytosis at least two distinct sites. At proximal site(s) 
G-proteins regulate the generation of second messengers 
which stimulate LH exocytosis. In addition, GTP-binding-
protein(s) are involved in exocytosis at a site distal to 
second messenger generation. 
6 APPENDIX 
CALCULATING METAL-LIGAND EQUILIBRIA 
When solutions contain more than one metal and/or ligand 
multiple equilibria exist. Although each equilibrium is 
simple to describe, multiple equilibria are complex and 
their solution is greatly aided by the use of a computer. 
The following equations were employed in a computer program 
which was written in Turbo PASCAL version 4 (Borland 
International, Scotts Valley, California) and run on an IBM 
XT computer. 
(a) Absolute stability constants (K) were adjusted for use 
at 37°C using the following equation (Martell and Smith, 
1976): 
logK = logKo + 0.00246 x H x (T-To) 
where 
T = desired temperature (usually 37°C) 
T0 = temperature for which stability constant is given. 
K = absolute stability constant at T 
K0 = absolute stability constant at T0 (usually 20-25 0°C; 
obtained from Fabiato (1981) 
H = enthalpy change; obtained from Martell and Smith (1976) 
Although routinely done, the adjustments for temperature 
made little difference to the calculations since in most 
cases -5 < H < 5, and T-T0 < 17. 
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(b) Apparent stability constants (KApp) take into account 
the existence of protonated forms of the ligands (such as 
EGTA, ATP) which may also bind ca2+ and Mg2+, although with 
smaller stability constants (i.e. lower affinity). Since the 
proportion of the ligand which is protonated varies with pH, 
its affinity for ca2+ and Mg2+ is pH dependent. KAPP is 
calculated from the absolute stability constants using the 
following equation (program 3 in Fabiato and Fabiato, 1979): 
where 
Km1, Km2 = absolute stability constant for binding of metal 
to unprotonated and monoprotonated ligand, 






SUM = 1 + K1[H+] + K1K2[H+]2 + K1K2K3[H+]3 + K1K2K3K4[H+]4 
where 
K1,K2,K3,K4 = absolute stability constants for binding of 
ligand to 1st, 2nd, 3rd, and 4th protons. 
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(c) The [metalltotal required to give specified [metallfree 
in the presence of specified [ligand] can be calculated from 
the following equations (modified from program 2 in Fabiato 
and Fabiato, 1979). 
[metalltotal = [metallfree + [metal.ligand(1)] + 
[metal.ligand(2)] .. etc ... 
where 
[metal.ligand] = concentration of metal bound to ligand 
= KAPP x [metallfree x [ligandlfree 
[ligandlfree can be calculated since the total ligand 
concentration is specified: 
[ligandltotal 
[ligandlfree = -------------------------------------------
(1 + [metal(x)lfreeKApp(x) + •. etc ... ) 
where x refers to all metals in the solution which bind the 
ligand. 
(d) Calculation of [metallfree from specified [metalltotal 
and [ligandltotal requires reiterative solution of the 
several equations, one for each ligand and metal in the 
solution (program 4 in Fabiato and Fabiato, 1979): 
[ligandltotal 
[ligandlfree = --------------------------------------
(1 + [metal(x)lfreeKApp(x) + .• etc .... ) 




(1 + [ligand(y)lfreeKApp(y) + •• etc ..... ) 
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where y refers to all ligands in the solution which bind the 
metal. 
As new results are calculated for [ligandlfree and 
[metal]free these are used in subsequent calculations. 
Iteration is terminated when new results differ from old 
results by< 0.005 percent. 
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Figure 1. calculated relationship between rca1±1~ 
ca/EGTA ratio at pH 6.6 and pH 1.1 
The Ca/EGTA ratios were calculated using the apparent 
stability constants given in Table 5 using a computer 
program described in the appendix. 
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Figure 2. Time course and concentration-dependence of a-
toxin-induced efflux of 2-deoxy[3Hlglucose 
After labelling with 2-deoxy[3H]glucose cumulative efflux of 
radioactivity in the presence of the indicated a-toxin 
concentration (added at t = 0) was measured. Results are 
expressed as a percentage of the initial total cellular 
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Figure 3. Comparison of LOH and [1HJuridine efflux in the 
presence of a-toxin 
121 
After labelling with [3H]uridine the efflux of radioactivity 
(O) and LDH (0) was measured over 20 min and is presented as 
a percentage of the initial total cellular radioactivity and 
LDH content, respectively. Similar results were obtained in 
three independent experiments. 
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Figure 4. a-Toxin permeabilization i Time of onset 
After labelling with 2-deoxy[3H]glucose cumulative efflux of 
radioactivity was measured and is presented as a percentage 
of the initial total cellular radioactivity. a-Toxin was 
either omitted<•> or present from either 0-5 min (0) or 0-
20 min (A). Similar results were obtained in three 
independent experiments. 
100 
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Figures. Time course of cal±-stimulated LH exocytosis 
Permeabilized cells in were equilibrated at 0°C for 30 min 
in stimulation buffer containing 30 mM CaEGTA with pCa 7 (0) 1 
5.5 (e), and 5 (~). LH exocytosis was initiated by 
replacing with identical buffer at 37°C which was exchanged 
at 3 minute intervals. The values at each time point 
represent LH released during the preceding 3 minute 
interval. The t = 0 points represent the rate of LH release 
(per 3 minutes) during the cold equilibration period. 
Similar results were obtained in six independent 
experiments . 
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Figure 6, cal± dependence of LH exocvtosis 
Permeabilized Ce) and intact (0) cells were equilibrated at 
0°C for 30 minutes in stimulation buffer containing 30 mM 
CaEGTA with the indicated [ca2+]free· LH exocytosis was 
initiated by replacing with identical buffer at 37°C and the 
LH released after 10 minutes was determined. Similar results 
were obtained in fourteen independent experiments. 
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Figure 7, Effect of CaEGTA (A) concentration and (B) 
equilibration time on LH exocytosis 
125 
In (A) permeabilized cells were equilibrated for 30 minutes 
at 0°C in stimulation buffer containing the indicated 
concentrations of CaEGTA with pCa 7 (0), 5.5 (e), and 5 (A). 
In (B) permeabilized cells were equilibrated for 10 (0) and 
30 <•> minutes at 0°C in stimulation medium containing 10 mM 
CaEGTA with the indicated [ca2+]free· Exocytosis was 
initiated by replacing with identical buffer at 37°C and LH 
released after 10 minutes was determined. Similar results 
were obtained in three (A) and two (B) independent 
experiments. 
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Figure 8, Ca2+-dependence of LH exocytosis at different EGTA 
concentrations 


































Figure 9 I E'f feet of PMA on ca2+-stimulated LH exocytosis 
Permeabilized cells were equilibrated for 30 minutes at 0°C 
in stimulation buffer containing 30 mM CaEGTA with the 
indicated [ca2+]free and 50 nM PMA (e) or vehicle alone 
[0.025% (v/v) Me2SO] (0). LH exocytosis was initiated by 
replacing with identical buffer at 37°C and the incubation 
was continued for 10 minutes. In the inset the same protocol 
was used as above except that the stimulation buffer pH was 
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Figure 10. Time course of phorbol ester-stimulated LH 
exocytosis 
Permeabilized cells in were equilibrated at 0°C for 30 
minutes in stimulation buffer containing 30 mM CaEGTA (pea 
7) and PMA 50 nM (I) or vehicle alone (0) [0.025% Me2SO 
(v/v)]. LH exocytosis was initiated by replacing with 
identical buffer at 37°C which was exchanged at 3 minute 
intervals. The values at each time point represent LH 
released during the preceding 3 minute interval. The t = 0 
points represent the rate of LH release (per 3 minutes) 
during the cold equilibration period. Similar results were 
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Figure 11 The effect of cAMP. with or without IBMX. on LH 
exocytosis 
Permeabilized cells were equilibrated at 0°C for 30 minutes 
in stimulation buffer containing 10 mM CaEGTA (pCa 7) and 
cAMP at the indicated concentration alone (0) or in the 
presence of 0.25 mM IBMX (e). Exocytosis was initiated by 
replacing with identical buffer at 37°C and the LH released 
after 10 minutes was determined. Similar results were 
obtained in three independent experiments. 
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Figure 12. Time course of cAMP-stimulated LH exocytosis 
Permeabilised cells were equilibrated at 0°C for 30 minutes 
in stimulation buffer containing 10 mM CaEGTA (pea 7) alone 
(0) or with 100 µM cAMP (e). Exocytosis was initiated by 
replacing with identical buffer at 37°C which was exchanged 
at 5 min intervals. The values at each time point represent 
the rate of LH release during the preceeding 5 min period. 
The zero time points represent the rate of LH release (per 5 
min) during the cold equilibration period. Similar results 
were obtained in three independent experiments. 
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Figure 13 The effect of IBMX concentration on cAMP-
stimulated LH exocytosis 
Permeabilized cells were equilibrated at 0°C for 30 minutes 
in stimulation buffer containing 10 mM CaEGTA (pea 7) and 
IBMX at the indicated concentration either alone (0) or in 
the presence of 100 µM cAMP (e). Exocytosis was initiated 
by replacing with identical buffer at 37°C and the LH 
released after 10 minutes was determined. Similar results 
were obtained in two independent experiments. 
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Figure 14. The effect of CAMP on Ca2+-stimulated LH 
exocytosis 
Permeabilized cells were equilibrated at 0°C for 30 minutes 
in stimulation buffer with 30 mM CaEGTA at the indicated 
[ca2+]free alone (0) or in the presence of cAMP (100 µM) 
p lus IBMX (0.25 mM) (e). LH exocytosis was initiated by 
replacing with identical buffer at 37°C and the LH released 
after 10 minutes was determined. In the inset the same 
protocol was used except the stimulation buffer pH was 7.1. 
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Figure 1s, The effect of PMA on cAMP-stimulated LH 
exocytosis 
Permeabilized cells were equilibrated at 0°C for 30 minutes 
in stimulation buffer containing 10 mM CaEGTA (pCa 7), IBMX 
(0.25 mM), and the indicated cAMP concentrations alone (0) 
or in the presence of 100 nM PMA <•). LH exocytosis was 
initiated by replacing with identical buffer at 37°C and the 
LH released after 10 minutes was determined. Similar results 
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Figure 16. The effect of cAMP on PMA-stimulated LH 
exocytosis 
Permeabilized cells were equilibrated at 0°C for 30 minutes 
in stimulation buffer containing 10 mM CaEGTA (pea 7), IBMX 
(0.25 mM), and the indicated PMA concentrations alone (0) or 
in the presence of 30 µM cAMP (e). LH exocytosis was 
initiated by replacing with identical buffer at 37°C and the 
LH released after 10 minutes was determined. Similar results 
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Figure 17. Ca1±-dependence of CAMP plus PMA-stimulated LH 
exocytosis 
Permeabilized cells were equilibrated at 0°C for 30 min in 
stimulation buffer containing 30 mM CaEGTA with the 
indicated pCa and with the following additions: None (O); 
CAMP (30 µM) plus IBMX (0.25 mM) <•>; PMA (100 nM) (O); or 
CAMP (30 µM) plus IBMX (0.25 mM) plus PMA (100 nM) <•>. LH 
exocytosis was initiated by replacing with identical buffer 
at 37°C and the LH released after 10 minutes determined. 
Similar results were obtained in two independent 
experiments. 
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Figure 18. The effects of GnRH on cAMP production and LH 
exocytosis in intact cells 
Cells at a density of 3 pituitaries per 6-well plate were 
stimulated for 1 hat 37°C in Buffer I with IBMX (0.25 mM) 
and the indicated GnRH concentrations, after which the LH 
released and the cellular cAMP were determined as described 
in Section 2. Similar results were obtained in two 
independent experiments. 
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Figure 19, The effect of MgATP depletion on LH exocytosis 
Permeabilized cells were equilibrated for the indicated 
times at 0°C with Buffer IC containing 30 mM CaEGTA with the 
following composition: <•> pCa 7, 5 mM MgATP; (0) pCa 5, no 
MgATP; <•> pCa 5, 5 mM MgATP. Exocytosis was initiated by 
replacing with identical buffer at 37°C and LH released 
after 10 minutes was determined. The time course of a-toxin-
induced loss of radioactivity from the trichloroacetic acid-
soluble [14c]adenosine labelled cellular pool (A) is shown 
for comparison. Similar results were obtained in three 
independent experiments. 
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Figure 20, Restoration of ca1.±-stimulated LH exocytosis by 
MgATP 
Permeabilized cells were equilibrated for 90 minutes at 0°C 
in Buffer IC containing 30 mM CaEGTA with pCa 7 (open) or 5 
(closed). MgATP (final concentration 5 mM) was added 
(circles) at the indicated times before stimulation. 
Exocytosis was initiated by replacing with identical buffer 
at 37°C with (circles} or without (bars) 5 mM MgATP and LH 
released after 5 minutes was determined. Similar results 
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Figure 21. MgATP dependence of {A) Ca2+-stimulated and {B) 
phorbol ester-stimulated LH exocytosis 
Permeabilized cells were equilibrated for 60 minutes at 0°C 
in Buffer IC containing the indicated MgATP concentrations 
and 30 mM CaEGTA with: (A) pCa 7 (0) or 5 (•); (B) pCa 8 
and 100 nM PMA <•> or vehicle alone [0.05% (v/v) Me2SO] (0). 
Exocytosis was initiated by replacing with identical buffer 
at 37°C and LH released after 10 minutes was determined. 
Similar results were obtained in four (A) and three (B) 
independent experiments. 
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Figure 22. Nucleotide-dependence of cal±-stimulated LH 
exocytosis 
Permeabilized cells were equilibrated for one hour at 0°C in 
Buffer IC containing 30 mM CaEGTA with pCa 7 (open) or pCa 5 
(closed) and the indicated nucleotide. Exocytosis was 
initiated by replacing with identical buffer at 37 °C and LH 
released after 10 minutes was determined. MgCl2 was include 
to maintain a [Mg2+]free of about 1 mM. Similar results were 
obtained in two independent experiments. 
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Figure 23. MgATP dependence of cAMP-stimulated LH exocytosis 
Pe r meabilized cells were equilibrated at 0°C for 90 minutes 
in Buffer IC containing 10 mM CaEGTA (pea 7) and the 
indicated MgATP concentration alone (0) or with cAMP (100 
µM) plus IBMX (0.25 mM) (e). Exocytosis was initiated by 
replacing with identical buffer at 37°C and the LH released 
after 10 min was measured. Similar results were obtained in 
three independent experiments. 
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Figure 24, PMA-stimulated LH exocytosis in cells refractory 
~ 
Permeabilized cells were equilibrated at O °C for 30 min in 
stimulation buffer containi n g 30 rnM CaEGTA with pea 8 (0,1) 
or 5 (~,•). LH exocytosis was initiated by replacing with 
identical buffer at 37 °C which was exchanged at 5 min 
intervals. Buffer added from t = 20 min onwards included PMA 
(100 nM)(•,•> or vehicle [0.05% Me2SO (v,v)] (0,~). The 
values at each time point represent the LH released during 
the preceding 5 min interval. The t = 0 point represents the 
rate of LH release (per 5 minutes) during the cold 
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Figure 25. The effect of staurosporine on PMA-. CaA±-. and 
,!!al±-stimulated LH exocvtosis 
Staurosporine was added at the indicated concentration 5 min 
after the start of the permeabilization step and was present 
until the end of the experiment. Permeabilized cells were 
equilibrated at O °C for 30 min in stimulation buffer 
containing 30 mM EGTA and with: pCa 8 plus 100 nM PMA (0) , 
pCa 5 <•>, or pBa 3 (~). LH exocytosis was initiated by 
replacing with identical buffer at 37 °C and LH released 
over the next 10 min was measured. LH release is expressed 
as a percentage of the release in the absence of 
staurosporine. Control values were(% of cellular LH ± 
range): pea 5, 15.7 ± 0.3; 100 nM PMA (pea 8), 4.3 ± 0.3; 
pBa 3, 10.2 ± 0.2. Similar results were obtained in three 
independent experiments. 
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Figure 26. The effect of staurosporine on combined cal±~ 
PMA-stimulated LH exocytosis 
Staurosporine (1 µM)(e,•) or vehicle [Me2SO, 0.1% (v,v)] 
(0,~) were added 5 min after the start of the 
permeabi lization step and were present until the end of the 
experiment. Permeabilized cells were equilibrated at O °C 
for 30 min in stimulation buffer containing 30 mM CaEGTA 
with the indicated [ca2+]free and 100 nM PMA (A,A) or 
vehicle [Me2SO 0.05% (v/v)] (O,e). LH exocytosis was 
initiated by replacing with identical buffer at 37 °C and LH 
released over the next 10 min was measured. Similar results 
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Figure 27. The effect of PMA-desensitization on Ca2+~ 
stimulated LH exocytosis 
Pituitary cells were exposed to PMA (500 nM) (~,•> or 
vehicle [Me2SO 0.25% (v/v)] (O,e) for 24 h after which the 
cells were washed and permeabilized. Permeabilized cells 
were equilibrated at O °C for 30 min in stimulation buffer 
containing 30 mM CaEGTA with the indicated [ca2+]free and 
100 nM PMA <•,•> or vehicle [Me2SO 0.05% (v/v)] (O,A). LH 
exocytosis was initiated by replacing with identical buffer 
at 37 °C and LH released over the next 10 min was measured. 
In (a) absolute amounts of LH released are shown whereas in 
(b) LH release is expressed as a percentage of cellular LH 
present immediately before stimulation. Similar results were 
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Figure 28. CA) Time-course of Ba2+- and ca2+-stimulated LH 
exocytosis and the effect of phorbol ester on cells 
refractory to Ba2+ , CB} The effect of Ba2+ on cells 
refractory to ca2+~ 
In (A) perm~abilized cells were equilibrated at O °C for 30 
min in stimulation buffer containing 30 mM EGTA with pCa 8 
(O,e), pea 5 (~), or pBa 3 (O,a). LH exocytosis was 
initiated by replacing with identical buffer at 37 °C which 
was exchanged at 5 min intervals. PMA 100 nM was added from 
t = 20 onwards (arrow) (I ,a). In (B) permeabilized cells 
were equilibrated at O °C for 30 min in stimulation buffer 
containing 30 mM EGTA with pCa 7 (O,•) or 5 (6,A). LH 
exocytosis was initiated by replacing with identical buffer 
at 37 °C which was exchanged at 5 min intervals. BaEGTA (30 
mM, pBa 3) was added from t = 20 onwards (arrow) (e,A). In 
(A) and (B) the values at each time point represents the LH 
released during the preceding 5 min interval and the t = 0 
point represents the rate of LH release (per 5 minutes) 
during the cold equilibration period. Similar results were 
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Figure 29. concentration dependence of BaA±-stimulated LH 
exocytosis 
Permeabilized cells were equilibrated at O °C for 30 min in 
stimulation buffer containing BaEGTA 30 mM with the 
indicated [Ba2+]free (0). LH exocytosis was initiated by 
replacing with identical medium at 37 °C and LH released 
over the next 10 minutes was measured. Similar results were 
obtained in three independent experiments. Also shown is the 
concentration dependence of ca2+-stimulated LH exocytosis 
(- - -) drawn from Figure 6. 
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Figure 30. Effect of triflµoperazine on Cal±-, Ba2+ -, and 
phorbol ester-stimulated LH exocvtosis 
Permeabilized cells were equilibrated at O °C for 30 min in 
stimulation buffer (EGTA 30 mM) with the indicated 
concentration of trifluoperazine and: pCa 7 <•>, pCa 7 plus 
100 nM PMA (0), pCa 5 (a), or pBa 3 (~). LH exocytosis was 
initiated by replacing with identical buffer at 37 °C and LH 
released over the next 10 min was measured. Similar results 
were obtained in two independent experiments. 
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Figure 31. Effect of calmidazolium on cal±- and phorbol 
ester-stimulated LH exocytosis 
Permeabilized cells were equilibrated at O °C for 30 min in 
stimulation buffer (CaEGTA 30 mM) with the indicated 
concentration of calmidazolium and: pCa 7 (0), pCa 7 plus 
100 nM PMA (A), or pCa 5 <•>. LH exocytosis was initiated by 
replacing with identical buffer at 37 °C and LH released 
over the next 10 min was measured. 
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Figure 32. stimulatory effects of guanine nucleotides on lH 
exocytosis 
(A) Time course. Permeabilized cells were equilibrated at 
0°C for 30 min in stimulation buffer containing 10 mM CaEGTA 
(pea 7) with no guanine nucleotide <•>, 300 µM GMPPNP (A), 
or 300 µM GTPyS (e). LH exocytosis was initiated by 
replacing with identical stimulation buffer at 37°C which 
was replaced at 5 min intervals. LH release at each time 
point represents the rate of LH released in the preceding 5 
min. The t = 0 point represents the rate of LH released per 
5 min during the 30 min equilibration period. Similar 
results were obtained in two independent experiments. 
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(B) Concentration-dependence. Permeabilized cells were 
equilibrated at 0°C for 30 min in buffer IC containing 10 mM 
CaEGTA (pea 7) with 2 mM MgCl2 (open) or 6.5 mM MgCl plus 6 
mM Na2ATP (closed) and the indicated concentration of GTPyS 
(O,e), GMPPNP (A), or GTP (t). LH exocytosis was initiated 
by replacing with identical buffer at 37°C and LH released 
after 20 min was determined. Similar results were obtained 
in five independent experiments. 
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Figure 33. Effect of [Ca2+J~ on GMPPNP-stimulated LH 
exocytosis 
Permeabilized cells were equilibrated at 0°C for 30 min in 
stimulation buffer containing 30 mM CaEGTA at the indicated 
[ca2+]free with<•> or without (0) 300 µM GMPPNP. LH 
exocytosis was initiated by replacing with identical buffer 
·at 37°C and LH released after 20 min was determined. In the 
inset the experiment was conducted at pH 7.1 to allow 
buffering of the [ca2+]free down to pCa 9. Similar results 
were obtained in three independent experiments. 
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Figure 34. Effect of GMPPNP on LH exocytosis in the presence 
of phorbol ester or cAMP 
Permeabilized cells were equilibrated at 0°C for 30 min in 
stimulation buffer containing 30 mM CaEGTA (pea 7) with<•> 
or without (0) GMPPNP (300 µM) and the indicated 
concentrations of PMA or cAMP. LH exocytosis was initiated 
·by replacing with identical buffer at 37°C and LH released 
after 20 min was determined. Similar results were obtained 
in three independent experiments. 
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Figure 35. Time-course of inhibition of cAMP/PMA-stimulated 
LH exocytosis by GTPxs 
Permeabilized cells were equilibrated at 0°C for 30 min in 
stimulation buffer containing 10 mM CaEGTA (pCa 7) with 
(closed) or without (open) 3 µM cAMP plus 10 nM PMA together 
with the following guanine nucleotides: none (O,e), 3 µM 
GMPPNP (O,a), or 3 µM GTPyS (6,~). LH exocytosis was 
initiated by replacing with identical stimulation buffer at 
37°C which was replaced at 5 min intervals. LH release at 
each time point represents the rate of LH released in the 
preceding 5 min. The t = 0 point represents the rate of LH 
released per 5 min during the 30 min equilibration period. 
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Figure 36. Inhibitory effects of GTPYS on ca2+-stimulated LH exocytosis 
An outline of the protocol used in all experiments examining 
GTPyS-inhibitory effects is shown. Permeabilized cells were 
equilibrated for 30 min at 0°C in buffer IC with 2 mM MgCl2, 
10 mM CaEGTA (pea 7) and the indicated concentration of GTP 
(t), GTPyS (O,e), or GMPPNP (A). Cells were then warmed to 
37°C and pre-incubated for 30 min in the same medium. This 
medium was removed and replaced with stimulation buffer 
[which contains MgATP (see Section 2.3)] with 30 mM CaEGTA 
at pCa 5 (closed) or pCa 7 (open) and LH released after 30 
min was determined. To allow the comparison of results from 
two experiments LH release is presented as percent of LH 
release evoked by pCa 5 in the absence of guanine 
nucleotides. Similar results were obtained in three 
independent experiments. 
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Figure 37, Inhibitory effects of GTPYS on cAMP- and PMA-
stimulated LH exocytosis 
155 
Permeabilized cells were equilibrated for 30 min at 0°C in 
buffer IC with 2 mM MgCl2, 10 mM CaEGTA (pCa 7) and the 
indicated concentration of GTPyS. Cells were then warmed to 
37°C and preincubated for 30 min in the same medium. This 
medium was removed and replaced with stimulation buffer 
containing 10 mM CaEGTA (pCa 7) with no addition<•) or with 
CAMP ( 300 µM) (A), PMA ( 100 nM) <+), or CAMP ( 300 µM) plus 
PMA (100 nM) (Y) and LH released after 30 min was 
determined. Similar results were obtained in three 
independent experiments. 
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Figure 38, Antagonism of GTPYS-inhibition by GTP. GMPPNP, 
and GDP 
Permeabilized cells were equilibrated for 30 min at 0°C in 
buffer IC containing 2 mM MgCl2 and 10 mM CaEGTA (pCa 7) 
without (open and closed bars) or with (hatched bars) 30 µM 
GTPyS, together with the indicated guanine nucleotides. 
Cells were then warmed to 37°C and pre-incubated for 30 min 
in the same medium. This medium was removed and replaced 
with stimulation buffer containing 30 mM CaEGTA at pCa 7 
(open bars) or pCa 5 (closed and hatched bars) and LH 
released after 30 min was determined. Similar results were 
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Figure 39. Inhibitory effects of GTPyS and ATPyS on ca2+_ 
stimulated LH exocytosis 
Permeabilized cells were equilibrated for 30 min at 0°C in 
buffer IC with 2 mM MgCl2, 10 mM CaEGTA (pea 7) and the 
indicated concentration of GTPyS (O,e) or ATPyS (~ 1 A) with 
(e,~) or without (0,~) 2 mM MgUDP. Cells were then warmed 
to 37°C and preincubated for 30 min in the same medium. This 
medium was removed and replaced with stimulation buffer 
containing 30 mM CaEGTA (pea 5) and the LH released after 30 
min was determined. Similar results were obtained in three 
independent experiments . 
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Figure 40. Inhibitory effects of GTPxs and ATPxs on 
cAMP/PMA-stimulated LH exocytosis 
Permeabilized cells were equilibrated for 30 min at 0°C in 
buffer IC with 2 mM MgCl2, 10 mM CaEGTA (pea 7) and the 
indicated concentration of GTPyS (0,•> or ATPyS (~,•> with 
<•,•> or without (O,~) 2 mM MgUDP. Cells were then warmed 
to 37°C and preincubated for 30 min in the same medium. This 
medium was removed and replaced with stimulation buffer 
containing 10 mM CaEGTA (pea 7), cAMP (30 µM), and PMA (100 
nM) and the LH released after 30 min was determined. Similar 
results were obtained in two independent experiments. 
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Figure 41. A hypothetical model depicting the dual 
stimulatory and inhibitory effects of GTPYS CGTPSl, 
The stimulatory effects result from activation of one or 
more heterotrimeric signal transducing G protein(s) (Gs, Gp, 
G?) coupled to cell-surface receptors (R), leading to 
generation of cAMP, DAG, and possibly other second 
messengers. The inhibitory effects result from binding to 
one or more unidentified GTP-binding protein(s) involved in 
exocytosis at a site distal to the generation of second 
messengers. 
R R R 







o l ! 
159 
